EurekaMag PDF full texts Chapter 35,067

Sims, N.A.; Clement Lacroix, P.; Daponte, F.; Bouali, Y.; Binart, N.; Goffin, V.; Coshigano, K.; Kopchick, J.; Baron, R.; Kelly, P.A. 2000: IGF-I treatment restores normal bone growth and remodeling in growth hormone receptor knockout mice. Journal of Bone and Mineral Research 15(Suppl 1): S267

Dubaquie, Y.; Lowman, H. 2003: IGF-I variants. Official Gazette of the United States Patent and Trademark Office Patents 1266(2)

Kalantie, E.; Fall, C.H.D.; Markku, S.; Riitta, K.; Dunkel, L.; Hilkka, Y.; Clive, O.; Sture, A.; David, B.J.P.; Tom, F.; Richard, H.I.G.; David, P.I.W.; Petteri, H.; Johan, E. 2003: IGF-I, IGFBP-1, and the link between early growth and adult cardiovascular risk. Pediatric Research 53(4 Part 2): 148A

Cerri, R.W.; Gonzales, L.; Ballard, P.L.; Cohen, P. 1999: IGF-I, IGFBP-3 and TGF-beta regulate growth and differentiation of H441 lung cells. Pediatric Research 45(4 Part 2): 86A

Dahlgren, J.; Fors, H.; Ankarberg, C.; Niklasson, A.; Hellstrom, A.; Albertsson Wikland, K.; Fisker, S.; Christiansen, J.S. 2000: IGF-I, IGFBP-3, estradiol and testosterone in adolescent males born small for gestational age. Growth Hormone and IGF Research 10(3): 175

Biedi, C.; Panetta, D.; Segat, D.; Saracino, S.; Cordera, R.; Maggi, D. 2003: IGF-I, but not insulin, phosphorylates p52 Shc in the lipid rafts and recruits fyn and Grb2 to these specialized subdomains. Diabetes 52(Suppl 1): A17

Ohkawa, N.; Shoji, H.; Kitamura, T.; Suganuma, H.; Yoshikawa, N.; Suzuki, M.; Lee, T.; Hisata, K.; Shimizu, T. 2010: IGF-I, leptin and active ghrelin levels in very low birth weight infants during the first 8 weeks of life. Acta Paediatrica 99(1): 37-41

Huber, S.; Gamper, N.; Fillon, S.; Friedrich, B.; Klingel, K.; Cohen, P.; Lang, F. 2000: IGF-I-induced activation of Kv1X channels in embryonic kidney cells in mediated by the serine/threonine kinase SGK1. Kidney and Blood Pressure Research 23(3-5): 216-217

Lu, Y.hong; Zi, Xiaolin; Pollak, Michael 2002: IGF-I-induced blockade of the inhibitory activity of trastuzumab on growth of SKBR3 breast cancer cells is associated with modulation of cell cycle molecules. Proceedings of the American Association for Cancer Research Annual Meeting 43: 422

Kuemmerle, J.F. 1999: IGF-I-mediated activation of protein kinase B and p70 S6 kinase in intestinal human muscle cells. Gastroenterology 116(4 Part 2): A620

Miyakawa, M.; Wakai, K.; Murakami, H.; Kato, K.; Nishimaki, M.; Isozaki, O.; Tsushima, T.; Takano, K. 2000: IGF-I-mediated cell proliferation and anti-apoptotic action using by the P13K-Akt and MAPK signaling pathways in a thyroid cancer cell line. Endocrine Journal 47(Suppl August): 205

Senthil, D.; Faulkner, J.L.; Abboud, H.E.; Choudhury, G.G.; Kasinath, B.S. 2000: IGF-I-stimulated eukaryotic initiation factor 4E binding protein 4E-BP1 phosphorylation Cross talk between PI 3-kinase and Erk-1 type MAP kinase pathways in mouse proximal tubular epithelial cells. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 427A

Adi, S.; Wu, N.Y.; Rosenthal, S.M. 1999: IGF-I-stimulated phosphorylation of Akt/protein kinase B and p70S6 kinase are differentially inhibited by LY294002 and wortmannin in skeletal muscle cells. Growth Hormone and IGF Research 9(5): 310

Rohrer, T.; Doetsch, J.; Marx, M.; Zepf, K.; Doerr, H.G. 2000: IGF-I/IGFBP-3 molar ratios in children with growth hormone deficiency on GH therapy. Hormone Research 53(Suppl 2): 66

Ekstrom, K.; Ritzen, E.M.; Bang, P. 2004: IGF-I/IGFBP-3 treatment in growth hormone insensitivity syndrome ; effects on GH secretion and insulin sensitivity. Growth Hormone and IGF Research 14(2): 113

Kabuta, T.; Hakuno, F.; Asano, T.; Takahashi, S.I. 2004: IGF-I/insulin receptor substrate -3 in the nucleus functions as a transcriptional co-regulator. Growth Hormone and IGF Research 14(2): 124-125

Valverde, A.M.; Mur, C.; Kahn, C.R.; Benito, M. 1999: IGF-I/insulin signalling in IRS-1-deficient brown adipocytes. Growth Hormone and IGF Research 9(5): 316

Ogino, S.; Kubo, S.; Cohen, M.L. 2000: IGF-II and IGF receptor type 1 expression in pediatric brain tumors. Laboratory Investigation 80(3): 195A

Seelig, A.S.; Schwartz, P.T.; Banz, C.; Jablonski, B.; Diedrich, K.; Ortmann, O. 2001: IGF-II and its receptors are present in human granulosa-luteal cells, and IGF-II acts as co-gonadotrophin on steroidogenesis. Human Reproduction 16(Abstract Book 1): 65

Galvin, C.D.; Hardiman, O.; Nolan, C.M. 1999: IGF-II binding to cultured cells A complication. Growth Hormone and IGF Research 9(5): 388-389

Birnbacher, R.; Dreer, B.; Muhllechner, P.; Schrocksnadel, H.; Spitzmuller, A.; Gschwendtner, B.; Heinz Erian, P. 1999: IGF-II concentrations in cord plasma are reduced after chronic exposure to smoking during pregnancy. Pediatric Research 45(4 Part 2): 237A

Kuepker, W.; Kressin, P.; Johannisson, R.; Al Hasani, S.; Diedrich, K. 1999: IGF-II gene expression in human testes with spermatogenetic failure. Human Reproduction 14(ABSTR BOOK 1): 34

Gronowicz, G.; Mccarthy, M.B.; Zhang, H. 2001: IGF-II induces apoptosis and IGF-I prevents glucocorticoid-induced apoptosis in primary human and rat osteoblasts. Journal of Bone and Mineral Research 16(Suppl 1): S358

Mitsiades, C.S.; Mitsiades, N.; Mcmullan, C.J.; Rung, A.L.; Anderson, K.C. 2003: IGF-II is a major proliferative/anti-apoptotic cytokine and a therapeutic target in MM, other hematologic neoplasias and solid tumors. Blood 102(11): 593a-594a

Maxwell, P.J.; Mcwilliams, S.; Van Den Berg, H.W. 2000: IGF-II secretion and IGF-I receptor expression by anti-estrogen resistant and estrogen independent breast cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 41: 787

Menouny, M.; Holthuizen, E.; Binoux, M.; Asfari, M. 1999: IGF-II transfected HIT-T15 cells exhibits modified cell proliferation and gene expression. Growth Hormone and IGF Research 9(5): 354

Kim, T.; Kim, H. 2003: IGF-II-mediated expression of angiogenetic factors VEGF and IL-8, and COX-2 in human keratinocytes. Journal of Investigative Dermatology 121(1): 0741

Amri, K.; Duong, J.P.; Vilar, J.; Belair, M.F.; Bruneval, P.; Merlet Benichou, C.; Lelievre Pegorier, M. 2000: IGF-II/M6P receptor localization in the fetal rat kidney. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 373A

Van Golen, C.M.; Feldman, E.L. 1999: IGF-IR activation and Bcl-2 transfection prevent early apoptotic events in human neuroblastoma cells. Growth Hormone and IGF Research 9(5): 344

Knowlden, J.M.; Iain, H.R.; Denise, B.; Robert, N.I. 2003: IGF-IR and EGFR crosstalk in tamoxifen resistant MCF-7 breast cancer cells. Breast Cancer Research and Treatment 82(Suppl 1): S171

Van Golen, C.M.; Feldman, E.L. 2001: IGF-IR signaling is regulated by integrin ligand binding in human neuroblastoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 839

Benini, S.; Inerot, S.; Picci, P.; Scotlandi, K. 1999: IGF-IR-mediated loop A peculiar feature of central high grade chondrosarcoma. Growth Hormone and IGF Research 9(5): 338

Xu, Q.; Wu, Z.G. 2000: IGF-PI3K-AKT signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma cells. Cell Biology International 24(12): 934

Uchiyama Tanaka, Y.; Matsubara, H.; Mori, Y.; Masaki, H.; Shibasaki, Y.; Iwasaka, T. 2001: IGF-beta signaling in glomerular mesangial cells Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-induced fibronectin expression. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 579A

Wang, S.N.; Lapage, J.; Hirschberg, R. 1999: IGF-binding protein-related protein-2 may play a role in proteinuria-accelerated interstitial fibrosis in diabetic nephropathy. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 691A

Elmlinger, M.W.; Jacobi, U.; Koscielniak, E.; Ranke, M.B. 1999: IGF-dependent binding of IGFBP-2 to integrins of tumor cells. Hormone Research 51(Suppl 2): 13

Mohan, S.; Baylink, D.J.; Amaar, Y. 2004: IGF-independent action of IGFBP-5 may involve intracellular binding to RAS association domain family protein, RASSF1C, and modulation of ERK pathway in osteoblasts. Growth Hormone and IGF Research 14(2): 110

Burrows, C.; Holly, J.M.P.; Perks, C.M. 2004: IGF-independent actions of IGFBP-3 involve cholesterol stabilised complexes and MAPK/Rho kinase activation. Growth Hormone and IGF Research 14(2): 110

Oh, Y.; Rosenfeld, R.G. 1999: IGF-independent actions of the IGF binding proteins. Rosenfeld, R G, Roberts, C T, Jr Contemporary Endocrinology; The IGF system: Molecular biology, physiology, and clinical applications 257-272

Holly, J.M.P.; Perks, C.M.; Stewart, C.E.H.; Gill, Z.P.; Maile, L.A.; Hollowood, A.D.; Fowler, C.A. 1999: IGF-independent effects of IGFBPs on apoptosis. Growth Hormone and IGF Research 9(5): 314

Stull, M.A.; Richert, M.M.; Wood, T.L. 1999: IGF-mediated growth of mammary epithelium during ductal development in the mouse. Growth Hormone and IGF Research 9(5): 320

Christiansen, J.J.; Fisker, S.; Gravholt, C.H.; Svenstrup, B.; Bennett, P.; Andersen, M.; Feldt Rasmussen, U.; Christiansen, J.S.; Jorgensen, J.O. Lunde 2004: IGF-related parameters in GH-treated hypopituitary women Dependency on estrogen supplementation and androgen status. Growth Hormone and IGF Research 14(2): 154

Teelken, A.W.; Schaaf, M.; Wilckzak, N.; Streefland, C.; De Keyser, J. 1999: IGF-system in serum and cerbrospinal fluid in multiple sclerosis. Growth Hormone and IGF Research 9(5): 387

Barg, E.; Wikiera, B.; Bieniasz, J.; Iwankiewicz, I.; Wasikowa, R. 2000: IGF1 in patients with IDDM and growth disorders. Hormone Research 53(Suppl 2): 169

Mani, A.M.; Fenwick, M.A.; Cheng, Z.; Sharma, M.K.; Singh, D.; Wathes, D.C. 2010: IGF1 induces up-regulation of steroidogenic and apoptotic regulatory genes via activation of phosphatidylinositol-dependent kinase/AKT in bovine granulosa cells. Reproduction 139(1): 139-151

Drost, A.C.; Ploeckinger, U.; Unterberg, A.; Quabbe, H.J.; Wiedenmann, B. 2001: IGF1 receptor modulation in primary pituitary tumour cells. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S54

Neou, P.; Stamogiannou, L.; Kafourou, A.; Zevlekari, I.; Bartsocas, C.S.; Margetakis, A. 1999: IGF1, IGFBP3, IGFBP1 serum levels in correlation with growth failure in infants with congenital heart disease. Hormone Research 51(Suppl 2): 42

Okubo, Y.; Kurimoto, M.; Kawamata, A.; Ishikawa, Y.; Isozaki, O.; Hizuka, N.; Fukuda, I.; Obara, T.; Takano, K. 2004: IGF1R expression and function in human thyroid tissues. Growth Hormone and IGF Research 14(2): 167

Deal, C.L. 1999: IGF2 Novel regulatory mechanisms. Growth Hormone and IGF Research 9(5): 331

Gray, S.; Von Horn, H.; Svechnikova, I.; Ekstrom, T.J. 2000: IGF2 in adult and pediatric liver cancer. International Journal of Molecular Medicine 6(Suppl 1): S6

Winkler, R.; Boussif, N.; Delacroix, L.; Hodzic, D. 2001: IGF2 mRNA and peptide overexpression and gene rearrangement in human primary colon cancers. International Journal of Molecular Medicine 8(Suppl 1): S73

Mccann, J.A.; Xu, Y.; Marchand, L.; Polychronakos, C. 2001: IGF2R as a candidate gene for autoimmune diabetes. American Journal of Human Genetics 69(4 Suppl): 519

Ricort, J.M. 2004: IGFBP signalling. Growth Hormone and IGF Research 14(2): 117

Kekki, M.; Kurki, T.; Paavonen, J.; Karkkainen, T.; Rutanen, E.M. 1999: IGFBP-1 in cervix as a predictor of prognosis in the patients with early pregnancy BV. International Journal of Gynecology and Obstetrics 67(Suppl 1): S46

Scharf, J.G.; Dombrowski, F.; Saile, B.; Eisenbach, C.; Demori, I.; Braulke, T.; Hartmann, H.; Ramadori, G. 2000: IGFBP-1 is highly induced during acute CCL4 liver injury and potentiates the IGF-I-stimulated proliferation of rat hepatic stellate cells. Journal of Hepatology 32(Suppl 2): 76

Brismar, K.; Wallerman, E.; Wajngot, A. 1999: IGFBP-1, a marker of impaired glucose tolerance test. Growth Hormone and IGF Research 9(5): 379-380

Nygren, J.O.; Thorell, A.; Brismar, K.; Ljungqvist, O.; Carlsson Skwirut, C.; Bang, P. 2000: IGFBP-1, proteolysis to IGFBP-3 and IGF-I bioavailability respond differently to insulin infusion performed before and after abdominal surgery. Clinical Nutrition 19(Suppl 1): 14

Hoeflich, A.; Schmidt, S.; Fisch, T.; Wanke, R.; Weber, M.M.; Seufferlein, T.; Wolf, E. 2004: IGFBP-2 as a modulator of IGF-I/GH-induced signaling cascades Effects on phosphorylation of PTEN and PDK. Growth Hormone and IGF Research 14(2): 111

Chen, C.; Tao, S.; Shai, R.; Mischel, P.; Liau, L.; Pintar, J.; Horvath, S.; Nelson, S.; Sawyers, C. 2004: IGFBP-2 as a surrogate marker for the PTEN/Akt signaling. Growth Hormone and IGF Research 14(2): 117

Elmlinger, M.W.; Deininger, M.H.; Schuett, B.S.; Ranke, M.B. 2001: IGFBP-2 correlates with malignancy A study on 50 CNS tumors. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S27

Wright, R.; Perks, C.; Holly, J.; Mason, H. 1999: IGFBP-2 in human ovarian follicles. Journal of Endocrinology 163(Suppl ): P40

Hoeflich, A.; Fettscher, O.; Lahm, H.; Wolf, E.; Weber, M.M. 2001: IGFBP-2 is involved in stress adaption of adrenocortical tumor cells. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S27

Hoeflich, A.; Nedbal, S.; Wu, M.; Lahm, H.; Kolb, H.; Wolf, E. 1999: IGFBP-2 overexpression impairs body weight gain in growth hormone transgenic mice. Growth Hormone and IGF Research 9(5): 392

Elmlinger, M.W.; Frommer, K.W.; Schuett, B.S.; Hoeflich, A.; Ranke, M.B. 2004: IGFBP-2-mediated gene expressions in tumor cells A DNA microarray Study. Growth Hormone and IGF Research 14(2): 169

Fowler, C.A.; Perks, C.M.; Farndon, J.R.; Holly, J.M.P. 1999: IGFBP-3 and -5 have opposing actions on paclitaxel induced apoptosis of human breast cancer cells, Hs578T. Growth Hormone and IGF Research 9(5): 368

Chang, Y.S.; Khuri, F.R.; Hassan, K.A.; Wiehle, S.A.; Ji, L.; Lotan, R.; Chun, K.H.; Hong, W.K.; Cristiano, R.; Lee, H.Y. 2003: IGFBP-3 and the farnesyl transferase inhibitor SCH66336 act synergistically to induce apoptosis in non-small cell lung cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1234

Martin, J.; Jambazov, S. 2004: IGFBP-3 binds to the extracellular matrix of breast epithelial cells. Growth Hormone and IGF Research 14(2): 169-170

Barrass, B.J.R.; Carter, J.; Bennion, P.; Lai, T.; Perks, C.M.; Persad, R.A.; Holly, J.M. 2004: IGFBP-3 directly modulates programmed cell death in prostate cancer but the effect switches between survival or death according to the apoptotic trigger. Growth Hormone and IGF Research 14(2): 153

Yang, J.; Kreimann, E.L.; Sikes, C.R.; Stephens, C.L.; Lin, S.H.; Peleg, S.; Olive, M.; Logothetis, C.J.; Karsenty, G.; Navone, N.M. 2003: IGFBP-3 effect in prostate cancer cells and osteoblasts. Proceedings of the American Association for Cancer Research Annual Meeting 44: 68-69

Vuguin, P.M.; Shim, M.L.; Cohen, P.; Barzilai, N. 2001: IGFBP-3 induces hepatic and peripheral insulin resistance in vivo. Diabetes 50(Suppl 2): A268

Franklin, S.L.; Ferry, R.J.Jr.; Cohen, P. 2001: IGFBP-3 inhibits VEGF-induced survival of endothelial cells, independently from the type 1 IGF receptor, through the PI3K/Akt signal transduction pathway. Diabetes 50(Suppl 2): A402

Barrass, B.J.R.; Lai, T.; Perks, C.M.; Persad, R.A.; Holly, J.M. 2004: IGFBP-3 inhibits cellular migration and adhesion in androgen resistant prostate cancer Implications for metastatic spread and disease progression. Growth Hormone and IGF Research 14(2): 154

Shim, M.; Cohen, P.; Liu, B.; Lee, H.; Kurie, J.; Law, R. 2000: IGFBP-3 inhibits glucose transport and blocks nuclear PPAR signalling. Growth Hormone and IGF Research 10(3): 144-145

Yang, S.T.; Shim, M.; Cohen, P. 2001: IGFBP-3 inhibits insulin action. American Zoologist 41(6): 1654

Hong, J.; Rechler, M.M. 2004: IGFBP-3 initiates apoptosis in human prostate cancer cells by FADD-dependent activation of caspase 8. Growth Hormone and IGF Research 14(2): 110-111

Kuemmerle, J.F. 2001: IGFBP-3 interacts with type V TGF-beta receptor to activate Smad2 and inhibit growth of human intestinal smooth muscle. Gastroenterology 120(5 Suppl 1): A508-A509

Bydlowski, S.P.; Pares, M.N.; Chamone, D.F.; Filho, O.B.D.arte 2000: IGFBP-3 is the solely IGF binding protein secreted by cultured monocyte-derived macrophages Effect of oxidized low density lipoprotein and human growth hormone. Journal of Submicroscopic Cytology and Pathology 32(3): 352

Rajah, R.; Cohen, P. 1999: IGFBP-3 mediates TNF-alpha induced apoptosis in the prostate cancer cell line, PC-3 Role of bcl-2 phosphorylation. Prostate 38(4): 352-353

Silha, J.V.; Sheppard, P.C.; Schwartz, J.; Gui, Y.; Dodd, J.G.; Murphy, L.J. 2004: IGFBP-3 overexpression attenuates prostate tumor growth in the presence of disrupted p53 action in IGFBP-3/large T antigen double transgenic mice. Growth Hormone and IGF Research 14(2): 118

Zachrisson, I.; Skwirut Carlsson, C.; Bang, P. 2000: IGFBP-3 protease induction by hyperglycemia in boys with type 1 diabetes. Journal of Pediatric Endocrinology and Metabolism 13(Suppl 4): 1227

Roschier, M.; Kuusisto, E.; Korhonen, P.; Salminen, A. 1999: IGFBP-5 and IGF1R mRNA are differentially expressed during apoptosis in cultured cerebellar granule cells. Society for Neuroscience Abstracts 25(1-2): 1529

Schedlich, L.; O'han, M.; Baxter, R. 2004: IGFBP-5 modulates the vitamin D response in bone cells. Growth Hormone and IGF Research 14(2): 170-171

Berfield, A.K.; Andress, D.L.; Abrass, C.K. 1999: IGFBP-5 stimulates Cdc42GAP aggregation and filopodia formation in migrating mesangial cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 542A

Kuemmerle, J.F. 2001: IGFBP-5 stimulates growth of human intestinal smooth muscle independently of IGF-I by activation of p38- and p42/44-MAP kinases. Gastroenterology 120(5 Suppl 1): A 20

Anonymous 2000: IGFBP2000 4th International Workshop on IGF Binding Proteins, Terrigal, New South Wales, Australia, October 26-29, 2000. Growth Hormone and Igf Research 10(4): A12-A38

Papadimitrakopoulou, Vassiliki A.; Brown, Erika; Liu, Diane; El Naggar, Adel; Hong, Waun Ki; Lee, Ho Young 2003: IGFBP3 loss predicts for adverse outcome in head and neck squamous cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 44: 98

Kansra, S.; Ewton, D.; Friedman, E. 1999: IGFBP3 mediates TGFbeta1 growth effects in colon cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 730

Iwabuchi, M.; Iwashita, M. 1999: IGFBPs in peritoneal fluid from pregnant women. Growth Hormone and IGF Research 9(5): 373

Hoffman, A.R.; Ceda, G.P. 2004: IGFs and aging: is there a rationale for hormone replacement therapy?. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 14(4): 296-300

Baserga, R.; Prisco, M.; Hongo, A. 1999: IGFs and cell growth. Rosenfeld, R G, Roberts, C T, Jr Contemporary Endocrinology; The IGF system: Molecular biology, physiology, and clinical applications 329-353

Shim, M.; Cohen, P. 1999: IGFs and human cancer: implications regarding the risk of growth hormone therapy. Hormone Research 51(Suppl 3): 42-51

Rosenthal, S.M. 1999: IGFs and skeletal muscle. Rosenfeld, R G, Roberts, C T, Jr Contemporary Endocrinology; The IGF system: Molecular biology, physiology, and clinical applications 497-516

Lund, P.Kay 1999: IGFs and the digestive tract. Rosenfeld, R G, Roberts, C T, Jr Contemporary Endocrinology; The IGF system: Molecular biology, physiology, and clinical applications 517-544

Leventhal, P.S.; Russell, J.W.; Feldman, E.L. 1999: IGFs and the nervous system. Rosenfeld, R G, Roberts, C T, Jr Contemporary Endocrinology; The IGF system: Molecular biology, physiology, and clinical applications 425-455

Singh, R.J.R.; Lin, H.; Suleiman, M.S.; Holly, J.M.P.; Stewart, C.E.H. 1999: IGFs in myocardial protection. Growth Hormone and IGF Research 9(5): 384

Drange, M.R.; Melmed, S. 1999: IGFs in the evaluation of acromegaly. Rosenfeld, R G, Roberts, C T, Jr Contemporary Endocrinology; The IGF system: Molecular biology, physiology, and clinical applications 699-720

Giudice, L.C. 1999: IGFs in the female reproductive system. Rosenfeld, R G, Roberts, C T, Jr Contemporary Endocrinology; The IGF system: Molecular biology, physiology, and clinical applications 379-405

Cianfarani, S.; Bonfanti, R.; Germani, D.; Boemi, S.; Puglianiello, A.; Vitale, S.; Riboni, S.; Boscherini, B. 1999: IGFs, IGFBPs and IGFBP-3 proteolysis in children with new-onset insulin-dependent diabetes mellitus. Hormone Research 51(Suppl 2): 43

Atzeni, F.; Sarzi Puttini, P.; Rossi, E.; Turiel, M.; Muzzupappa, S. 2002: IGG antianticardiolipin antibodies titer is strongly associated with new thromboembolic episodes in primary antiphospolipid syndrome A five-year prospective study. Lupus 11(9): 599

Johansson, I. 2002: IGG separation medium. Official Gazette of the United States Patent and Trademark Office Patents 1259(1)

Wouw Van De, B.A.M.; Laheij, R.J.F.; Schneeberger, P.M.; Boer De, W.A. 1999: IGG serology at 6 months is a reliable predictor for cure of H pylori infection. Gastroenterology 116(4 Part 2): A357

Duranti, M.A.; Cunha Neto, E.; Gruber, A.; Iwai, L.K.; Umezawa, E.S.; Kalil, J.; Zingales, B. 1999: IGG subclass and fine epitope specificity of anti-B13 antibodies in Latin America chagasic sera. Memorias do Instituto Oswaldo Cruz 94(Suppl 2): 178

Horita, T.; Ichikawa, K.; Yasuda, S.; Takeuchi, R.; Amasaki, Y.; Atsumi, T.; Koike, T. 2000: IGM phosphatidylserine dependent monoclonal antiprothrombin antibody from a patient with antiphospholipid syndrome. Journal of Autoimmunity 15(2): A20

Hogmire, H.W.; Winfield, T. 1999: IGR evaluation I, 1998. Saxena, K N Arthropod Management Tests 15

Hogmire, H.W.; Winfield, T. 1999: IGR evaluation II, 1998. Saxena, K N Arthropod Management Tests 16

Gu, K.; Chew, W.; Sim, W.M.; Kai, C.S.; Yian, T.B.; Heng, D. 2002: IGT may not be a predicator of hypertension; results from Singapore IGT follow up study, 1992-2000. American Journal of Epidemiology 155(11 Suppl): S23

Ray, S.D.; Parikh, H.; Ali, S.; Bagchi, D. 2000: IH636 grape seed proanthocyanidin extract exposure significantly attenuates dimethylnitrosamine -induced liver cancer and mortality in ICR mice. Proceedings of the American Association for Cancer Research Annual Meeting 41: 460

Bartlett, J.M.S.; Going, J.J.; Mallon, E.A.; Reeves, J.R.; Watters, A.D.; Richmond, J.; Donald, B.; Ferrier, R.; Cooke, T.G. 2000: IHC vs FISH for assessing HER2 overexpression in breast cancer. European Journal of Cancer 36(Suppl 5): S53

Swinger, K.K.; Rice, P.A. 2004: IHF and HU: flexible architects of bent DNA. Current Opinion in Structural Biology 14(1): 28-35

Murphy, M.; Curtin, D.; Dolan, V.; Hensey, C.; Kretzler, M.; Schlondorff, D.; Godson, C.; Brady, H.R.; Martin, F. 2003: IHG-1 enhances TGF-beta-induced transcriptional activation and its expression is increased in diabetic nephropathy. Journal of the American Society of Nephrology 14(Abstracts Issue): 127A-128A

Mcmahon, R.A.; Murphy, M.; Howlin, J.; Godson, C.; Martin, F.; Brady, H.R. 2000: IHG-1 is encoded by a conserved evolutionarily ancient gene and expressed in human renal mesangial cells exposed to high glucose. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 647A-648A

Mcmahon, R.; Murphy, M.; Godson, C.; Martin, F.; Brady, H.R. 1999: IHG-2, a mesangial cell gene differentially induced in high glucose is human drm/gremlin. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 686A-687A

Standaert, D.G. 2003: II A2A receptor modulation for symptomatic therapy in Parkinsons disease Adenosine A2A receptor modulation of motor systems in PD. Neurology 61(11 Suppl 6): S30-S31

Nikolova, D.; Marinova, E.; Altunkova, I.; Bichkidjieva, E.; Alexieva, B. 2000: II Berberine suppression in the development of experimental autoimmune tubulointerstitial nephritis in BALB/c mice. Dokladi na B"lgarskata Akademiya na Naukite 53(9): 105-108

Tamura, N. 2001: II Current situation and conservation of squirrels in foreign countries. Honyurui Kagaku 41(2): 137-148

Anonymous 2004: II Ecosystems and metabolism. Ecological Modelling 178(1-2): 41-42, Ober 15

Vicente Herrero, M.T.; Lainez, M.J.A.; Diaz, S.; Correos Headache Study Group 2003: II Headache conditions in the Spanish Mail Service employees Characteristics of the pain and population affected. Cephalalgia 23(7): 604

Anonymous 2001: II Hungarian Cell Analysis Conference, Budapest, Hungary, May 4-6, 2000. Cytometry 46(3): 193-214

Hakim, A.A. 2002: II wP53 suppresses breast cell malignancy by controlling the cell cycle arrest and apoptosis. International Journal Of Cancer Suppl.(13): 340-341

Von Briel, C.; Betticher, D.; Ris, H.B.; Greiner, R.H. 1999: III A/B non small cell lung cancer Quickly alternating, radical radio-/chemotherapy with few side effects. International Journal of Radiation Oncology Biology Physics 45(3 Suppl): 383

Pedata, F.; Pugliese, A.M.; Melani, A.; Gianfriddo, M. 2003: III A2A receptors in neuroprotection of dopaminergic neurons. Neurology 61(11 Suppl 6): S49-S50

Yatake, H.; Tamura, N. 2001: III Ecological studies on conserving the Japanese squirrel. Honyurui Kagaku 41(2): 149-157

Anonymous 2004: III General systems, ecological modeling and symbols. Ecological Modelling 178(1-2): 81-82, Ober 15

Anonymous 2000: III Medical-Academic Congress, the Medical Faculty of Ribeirao Preto, Brazil, Ribeirao Preto, Brazil, October 5-7, 2000. Medicina (Ribeirao Preto) 33(Suplemento 1): 7-33

Vicente Herrero, M.T.; Lainez, M.J.A.; Diaz, S.; Correos Headache Study Group 2003: III-Social and labour impact of headache conditions in the Spanish Mail Service employees. Cephalalgia 23(7): 754

Rolbiecki, L.; Rokicki, J. 2000: IIIrd stage larvae of Anisakis simplex in pike perch from the Vistula Lagoon, Poland. Acta Parasitologica 45(3): 263

Abali, H.; Koc, Y.; Oyan, B.; Tekin, F.; Tekuzman, G.; Kansu, E. 2002: IIVP Salvage Regimen Induces High Response Rates in Patients with Relapsed HD or NHL Prior to Autologous HSCT. Blood 100(11): Abstract No. 4714

Uno, Akitake; Et Al 2001: IIa+IIc type early cancer of duodenal bulbus, report of a case. Stomach and Intestine 36(12): 1550-1552

Kusunoki, Hiroaki; Et Al 2002: IIa+IIc type early gastric cancer with cystic dilatation of ordinary glands, report of a case. Stomach and Intestine 37(11): 1374-1376

Hosokawa, Osamu; Et Al 2001: IIc type intramucosal duodenal cancer detected on the inferior duodenal angulus, report of a case. Stomach and Intestine 36(12): 1547-1549

Baeuerle, P.; Cohen, L. 1999: IKAP nucleic acids. Official Gazette of the United States Patent and Trademark Office Patents 1221(1)

Cohen, L.; Baeuerle, P. 2001: IKAP proteins and methods. Official Gazette of the United States Patent and Trademark Office Patents 1242(2)

Wulff, H.; Ghanshani, S.; Miller, M.J.; Fernandez, H.; Cahalan, M.D.; Chandy, K.G.orge 2001: IKCa1 up-regulation during T-cell activation and characterization of the TRAM-34 binding site. Biophysical Journal 80(1 Part 2): 242a-243a

Karin, M. 2003: IKK A master regulator of innate and adaptive immune responses. Toxicological Sciences 72(S-1): 116

Chen, F.; Castranova, V.; Li, Z.W.; Karin, M.; Shi, X. 2003: IKK deficiency causes oxidative stress and prolonged JNK activation induced by arsenic. Free Radical Biology and Medicine 35(Suppl 1): S61-S62

Sizemore, N.; Lerner, N.; Stark, G.R. 2002: IKK phosphorylates and regulates transcriptional activation of both p65 NFkappaB and beta-catenin. Journal of Interferon and Cytokine Research 22(Suppl 1): S-109-S-110

Rothe, M.; Cao, Z.; Regnier, C. 2002: IKK-alpha proteins nucleic acids and methods. Official Gazette of the United States Patent and Trademark Office Patents 1264(2)

Luedde, T.; Assmus, U.; Wuestefeld, T.; Pasparakis, M.; Manns, M.P.; Trautwein, C. 2003: IKK-beta independent pathways can activate NF-KB in vivo and protect from liver injury. Hepatology 38(4 Suppl 1): 566A

Carvalho Filho, M.; Ueno, M.; Oliveira, R.; Carvalheira, J.; Gontijo, J.; Velloso, L.; Saad, M. 2003: IKK/IkB/NFkB and JNK1 pathways are increased in muscle and adipose tissue of SHR Possible mechanisms of insulin resistance. Diabetes 52(Suppl 1): A326

Takemoto, Y.; Sakai, Y.; Hashimoto, Y. 2003: IKK3 kinase. Official Gazette of the United States Patent and Trademark Office Patents 1271(2)

Dejardin, E.; Haas, E.; Ware, C.; Green, D. 2001: IKKa and IKKb have different roles in LTbR-mediated NF-kB activation. Journal of Leukocyte Biology Suppl: 22

Assmus, U.B.; Wuestefeld, T.; Klein, C.; Pasparakis, M.; Manns, M.P.; Trautwein, C. 2004: IKKgamma but not IKK is essential for liver regeneration after partial hepatectomy. Journal of Hepatology 40(Suppl 1): 18

Yemelyanov, A.; Yao, Y.J.; Budunova, I.V. 2003: IKKi is a component of the positive feedback loop involved in the constitutive activation of NF-kappaB in prostate carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 852

Besana, A.; Rocchetti, M.; Zaza, A. 2000: IKr and ventricular repolarization rate may interact in a positive feed-back loop. European Heart Journal 21(Abstract Suppl): 63

Heath, B.M.; Terrar, D.A. 2000: IKr is enchanced by protein kinase C through a reduction in C-type inactivation in guinea-pig myocytes. Biophysical Journal 78(1 Part 2): 213A

Gerlach, U. 2001: IKs channel blockers Potential antiarrhythmic agents. Drugs of the Future 26(5): 473-484

Van Opstal, J.M.; Volders, P.G.; Stengl, M.; Martel, E.; Gerlach, U.; Spatjens, R.L.; Beekman, J.D.; Sipido, K.R.; Vos, M.A. 2003: IKs contributes importantly to ventricular repolarization in conscious dogs. Journal of the American College of Cardiology 41(6 Suppl A): 112A

Berthier Schaad, Y.; Plantinga, L.; Liu, Y.; Fink, N.; Klag, M.J.; Coresh, J.; Smith, M.W. 2003: IL 10 polymorphisms and risk of cardiovascular disease in the CHOICE cohort. American Journal of Human Genetics 73(5): 392

Ceponis, P.J.; Mckay, D.M. 2000: IL 4- and IL 13-induced increases in epithelial permeability are dependent on a phosphatidylinositol 3-kinase , rather than a STAT 6 pathway. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A612

Palsson, E.M.; Popoff, M.R.; O'neill, L.A.J. 1999: IL-1 activates Ras and Rap in EL4NOB-1 cells A role for ras in p38 MAPK activation by IL-1. Cytokine 11(11): 939

Venkert, R.W.; Werman, A.; Apte, R.N. 2003: IL-1 alpha is the cause of IBD in BALB/C mice. European Cytokine Network 14(Suppl 3): 64

Wu, D.T.; Mcmanus, C.; Berman, J.W. 2000: IL-1 and IFN-gamma potential roles in HIV-1 infection of the central nervous system. Journal of Neurovirology 6(Suppl 1): S119

Sims, J.E. 2002: IL-1 and IL-18 receptors, and their extended family. Current Opinion in Immunology 14(1): 117-122

Lang, D.; Terstesse, M.; Dohle, F.; Bangen, P.; Banas, B.; Pauels, H.G.; Heidenreich, S. 2000: IL-1 and LPS regulate tissue factor expression in mesangial cells in a protein kinase C -dependent pathway Implications of apoptosis for release of TF-activity. Immunobiology 203(1-2): 142-143

Keys, B.; Hatthachote, P.; Gillespie, J.I. 1999: IL-1 and TGFbeta1 stimulate the release of IL-8 from human myometrial smooth muscle cells in vitro. Journal of Physiology (Cambridge) 521P: 64P-65P

Graves, D.T.; Chen, C.; Hertzberg, M.; Jiang, Y.L. 1999: IL-1 and TNF are not required for gram negative bacteria-induced osteoclastogenesis and bone loss. Journal of Bone and Mineral Research 14(Suppl 1): S327

Homaidan, Fadia R.; Chakroun, Iman; El Sabban, Marwan E. 1999: IL-1 and ceramide induce COX-2 in intestinal epithelial cells with no effect on apoptosis. Gastroenterology 116(4 Part 2): A738

Homaidan, R.; Chakroun, I.; Dbaibo, G.S.; El Sabban, M.E. 2000: IL-1 and ceramide regulate NF-kB and bcl-2 in intestinal epithelial cells through distinct pathways. Acta Physiologica Scandinavica 170(4): A80-A81

Homaidan, Fadia R.; Chakroun, Iman; Dbaibo, Ghassan S.; El Sabban, Marwan E. 1999: IL-1 and ceramide regulate NF-kappaB and bcl-2 in intestinal epithelial cells through distinct pathways. Gastroenterology 116(4 Part 2): A888

Rothwell, N.J. 2002: IL-1 and neurodegeneration. Journal of Physiology (Cambridge) 543P: 25S-26S

Sue, W.; Griffin, T. 2000: IL-1 and the cytokine cycle in Alzheimers disease. Journal of Neurochemistry 74(Suppl ): S52

Ferri, C.C.; Ferguson, A.V. 2004: IL-1 beta Depolarizes Magnocellular Paraventricular Nucleus Neurons via a Prostaglandin-dependant Mechanism. FASEB Journal 18(4-5): Abstract 833

Kuwagata, Y.; Oda, J.; Tanaka, H.; Sugimoto, H. 1999: IL-1 beta alters the relationship between systemic oxygen delivery and consumption by slanting the supply-independent line. FASEB Journal 13(4 Part 1): A26

Roux, J.; Kawakatsu, H.; Howard, M.; Lee, H.; Frank, J.A.; Su, G.; Pittet, J.F.ancois 2004: IL-1 beta decreases alveolar transepithelial ion transport in vitro. FASEB Journal 18(4-5): Abstract 684

Basini, G.; Baratta, M.; Bussolati, S.; Mainardi, G.L.; Tamanini, C. 1999: IL-1 beta fragment stimulates apoptosis in bovine granulosa cells. Journal of Endocrinology 163(Suppl ): P38

Kon, A.; Sasaki, H.; Fujimura, Y.; Higashi, K.; Tamai, K.; Sawamura, D.; Hanada, K.; Mauviel, A.; Uitto, J.; Hashimoto, I. 2000: IL-1 beta/AP-1 upregulates type VII collagen gene expression at the transcriptional level. Journal of Dermatological Science 23(3): 207

Ikegami, M.; Willet, K.; Kramer, B.W.; Moss, T.; Newnham, J.; Sly, P.; Jobe, A.H. 2001: IL-1 but not TNFalpha induce inflammation and lung maturation in preterm lambs. Pediatric Research 49(4 Part 2): 262A

Janesko, K.L.; Satchell, M.A.; Kochanek, P.M.; Adelson, P.D.; Ruppel, R.A.; Graham, S.H.; Clark, R.S.B. 2000: IL-1 converting enzyme , IL-1, and cytochrome c in CSF after head injury in infants and children. Journal of Neurotrauma 17(10): 956

Tebo, J.; Frevel, M.; Williams, B.R.G.; Hamilton, T.A. 2001: IL-1 differentially stabilizes ARE containing mRNAs. Journal of Leukocyte Biology Suppl: 24

Sims, J.E.; Renshaw, B.R. 2004: IL-1 eta DNA and polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1283(4)

Fox, S.W.; Chambers, T.J. 2000: IL-1 increases actin ring formation in in-vitro-derived osteoclast-like cells but not in osteoclast isolated ex-vivo. Journal of Pathology 190(Suppl): 7A

Onodera, M.; Murota, S.; Morita, I. 2003: IL-1 induced COX-1 gene as well as COX-2 in primary cultured synovial cells isolated from rheumatoid arthritis. Inflammation Research 52(Suppl 2): S 172

Tebo, J.; Hamilton, T. 2002: IL-1 induced mRNA stabilization involves a priming and triggering phase. Journal of Interferon and Cytokine Research 22(Suppl 1): S-125

Dimari, J.F.; Mifflin, R.C.; Saada, J.I.; Adegboyega, P.A.; Powell, D.W. 2001: IL-1 induces COX-2 protein synthesis in intestinal stromal cells via MAPK and PKC-dependent pathways. Gastroenterology 120(5 Suppl 1): A 5

Kandere Grzybowska, K.; Kempuraj, D.; Letourneau, R.; Asare, A.; Athanasiou, A.; Theoharides, T.C. 2002: IL-1 induces differential release of IL-6 from human mast cells. FASEB Journal 16(4): A332

Yu, X.Q.; Li, J.H.; Chen, Y.X.; Lan, H.Y. 2000: IL-1 induces osteopontin expression through the activation of p38 MAPK. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 449A

Li, Q.; Engelhardt, J. 2002: IL-1 induction of NFkB is regulated through the redox activation of NIK. Free Radical Biology and Medicine 33(Suppl 2): S353

Nilkaeo, A.; Ongsakul, M. 2003: IL-1 inhibition of trophoblast proliferation is mediated by the induction of apoptosis. Inflammation Research 52(Suppl 2): S 162

Bry, K.; Tichelaar, J.; Lappalainen, U. 2002: IL-1 inhibits production of clara cell secretory protein in mouse lungs. Pediatric Research 51(4 Part 2): 474A

Helmby, H.; Grencis, R.K. 2000: IL-1 is an important regulator of Th2 mediated resistance to gastro-intestinal nematode infection. Immunology 101(Suppl 1): 84

Fernandez, N.; Pulido, E.J.; Shames, B.D.; Poole, A.W.; Mcintyre, R.C.Jr 2000: IL-1 mediates hepatic C-X-C chemokine-induced neutrophil recruitment in endotoxemia. Journal of Investigative Medicine 48(1): 95A

Ouellette, Y.; Pazin, D. 2003: IL-1 modulation of connexin 43 in wild-type and connexin 40 deficient endothelial cells. Pediatric Research 53(4 Part 2): 46A

Dennis, R.; Trappe, T.A.; Simpson, P.; Huang, E.; Nagarajan, R.; Bearden, E.; Carroll, C.; Gurley, C.; Kornman, K.; Peterson, C.A. 2004: IL-1 polymorphisms are associated with the inflammatory response to resistance exercise. FASEB Journal 18(4-5): Abstract 477

Rad, R.; Prinz, C.; Zeitner, M.; Neu, B.; Becker, I.; Schepp, W.; Gerhard, M. 2002: IL-1 polymorphisms predispose to severe histological changes of the gastric mucosa in the presence of type 1 Helicobacter pylori strains. Gut 51(Suppl 2): A53

Marak, R.E.; Sheng, J.G.; Griffin, W.S.T. 1999: IL-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Modern Pathology 12(1): 172A

Benito Ruiz, P. 2002: IL-1 receptor antagonist. Revista Espanola de Reumatologia 29(3): 120-124

Van Dijk, S.; Stone, K.L.; Hannon, R.A.; Lui, L.L.; Sorrell, J.A.; Eastell, R.; Cummings, S.R.; Duff, G.W. 2000: IL-1 receptor antagonist gene polymorphism associated with age of menopause. Journal of Bone and Mineral Research 15(Suppl 1): S537

Ischenko, A.M.; Masurov, V.I.; Raymuev, K.V.; Ketlinsky, S.A. 2002: IL-1 receptor antagonist in therapy of rheumatoid arthritis; phase I clinical trials. Journal of Interferon and Cytokine Research 22(Suppl 1): S-189

Nesic, O.; Svrakic, N.M.; Xu, G.Y.; Mcadoo, D.; High, K.W.; Hulsebosch, C.; Perez Polo, R. 2001: IL-1 receptor antagonist prevents apoptosis of spinal cord cells and caspase-3 activation after injury. Journal of Neurochemistry 78(Suppl 1): 65

Tuma, E.; Eigler, A.; Toepfer, M.; Endres, S.; Schiffl, H. 2000: IL-1 receptor antagonist production by isolated mononuclear cells is a better indicator of bioincompatibility of hemodialysis membranes than that by stimulated whole blood. Nephron 86(2): 220-221

Haskill, J.S.; Ralph, P. 1999: IL-1 receptor antagonists medicaments. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2511

Boraschi, D.; Bossu, P.; Ruggiero, P.; Macchia, G.; Tagliabue, A.; Frigerio, F.; Grifantini, R.; Frascotti, G.; Grandi, G. 1999: IL-1 receptor antagonists with enhanced inhibitory activity. Official Gazette of the United States Patent and Trademark Office Patents 1224(2)

Abramov, V.M.; Kulikova, N.L.; Khlebnikov, V.S.; Vasiliev, A.M.; Karlyshev, A.M.; Kosarev, I.V.; Vasilenko, R.N.; Sakulin, V.K.; Kozlovskaya, G.D.; Pchelintsev, S.Y.; Shcherbakov, G.Y. 2002: IL-1 receptors on host cells as one of mooring bitts for Yershinia pestis. Journal of Interferon and Cytokine Research 22(Suppl 1): S-193

Sawaji, Y.; Kashiwagi, M.; Nagase, H.; Clark, A.R.; Saklatvala, J. 2003: IL-1 reciprocally regulates TIMP-3 and ADAMTS proteinases in articular cartilage. European Cytokine Network 14(Suppl 3): 66

Tomita, M.; Okada, Y.; Alander, C.; Lorenzo, J.; Raisz, L.G.; Pilbeam, C.C. 2000: IL-1 regulation of osteoblastic differentiation in murine bone marrow and primary osteoblastic cultures. Journal of Bone and Mineral Research 15(Suppl 1): S508

Singer, C.F.; Kronsteiner, N.; Hudelist, G.; Marton, E.; Walter, I.; Kubista, M.; Czerwenka, K.; Martin, S.; Seifert, M.; Kubista, E. 2003: IL-1 system and sex steroid receptor expression in human breast cancer IL-1alpha protein secretion is correlated with malignant phenotype. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1241-1242

Singer, C.F.; Kronsteiner, N.; Marton, E.; Walter, I.; Kubista, M.; Czervenka, K.; Schreiber, M.; Seifert, M.; Kubista, E. 2001: IL-1 system and sex steroid receptor gene expression in human endometrial cancer. Proceedings of the American Association for Cancer Research Annual Meeting 42: 781

Oliveira, J.G.G.; Xavier, P.; Sampaio, S.; Mendes, A.A.; Pestana, M. 2001: IL-1, IL-17 and cAMP post-kidney transplantation. Nephrology Dialysis Transplantation 16(6): A199

Baranao, R.I.; Martin, A.; Kopcow, L.; Marconi, G.; Puigdomenech, E.; Speranza, G.; Diradourian, M.; Quintana, R. 2000: IL-1, IL-6 and VEGF in granulosa cells culture conditioned media from patients with hippo, normand hyper response to stimulation for IVF. Biocell 24(3): 261

Caramona, M.M.; Mendes, A.F.; Carvalho, A.P.; Lopes, M.C. 2003: IL-1-induced AP-1 activation requires reactive oxygen species but does not regulate iNOS expression in articular chondrocytes. Toxicology Letters (Shannon) 144(Suppl 1): s122

Simbirtsev, A.; Aznabaeva, L.; Variouchina, E.; Konusova, V.; Kotov, A.; Ketlinsky, S. 2001: IL-1-induced changes in the local inflammation in humans. Inflammation Research 50(Suppl 3): S172

Kishore, R.; Kolosov, M.; Major, J.; Hamilton, T.; Tebo, J. 1999: IL-1-mediated stabilization of GRO-alpha mRNA depends on sequences in both 5 and 3 untranslated regions. Journal of Interferon and Cytokine Research 19(Suppl 1): S103

Sims, J.E.; Virca, G.D.; Bird, T.A.; Anderson, D.M. 2000: IL-1/TNF-alpha-activated kinase , and methods of making and using the same. Official Gazette of the United States Patent and Trademark Office Patents 1235(4)

Barnes, P.J. 2001: IL-10: a key regulator of allergic disease. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 31(5): 667-669

Jiang, H.; Yang, X.F.; Wynn, C.; Soriano, R.; Krishnan, K.; Fujimura, T.; Kobayashi, M. 2001: IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. Transplantation Proceedings 33(1-2): 510-513

Mangia, A.; Santoro, R.; D'apolito, O.; Nardella, G.; Piepoli, G.; Andriulli, A. 2001: IL-10 AA-1117 genotype predicts long term response to antiviral therapy. Hepatology 34(4 Pt 2): 307A

Mangia, A.; Santoro, R.; D'apolito, O.; Lacobellis, A.; Andruilli, A. 2002: IL-10 ATA haplotype and 1st interon IFN-gamma polymorphisms are more frequent in PTS with spontaneous HCV clearance. Journal of Hepatology 36(Suppl 1): 117

Hudson, L.L.; Rocca, K.M.; Pandey, J.P. 2004: IL-10 Genotypes in Systemic Sclerosis. FASEB Journal 18(4-5): Abstract 779

Lin, M.T.; Storer, B.; Martin, P.J.; Tseng, L.H.; Gooley, T.; Chen, P.J.; Hansen, J.A. 2002: IL-10 Promoter Polymorphism, Graft-Versus-Host Disease and Mortality Following Hematopoietic Cell Transplantation. Blood 100(11): Abstract No. 1625

Perez, L.L.; Laudanski, K.; Miller Graziano, C. 2003: IL-10 addition during MO to DC differentiation both up-regulates PD-1L on immature DC and increases their macrophage characteristic. Journal of Leukocyte Biology Suppl: 27

Guzman, E.A.; Hill, L.L.; Owen Schaub, L.B. 2000: IL-10 alters Fas/Fas ligand induced cell death in activated lymphocytes. FASEB Journal 14(6): A1088

Saban, R.; Hammond, T.G.; Saban, M.R.; Nguyen, N.B.ch 2000: IL-10 alters the time-course of gene-expression in response to LPS-induced cystitis. Molecular Biology of the Cell 11(Suppl): 436a-437a

Dillman, R.O.; Schiltz, P.M.; Spencer, K.S.; Schwartzberg, L.; Barth, N.M.; Deleon, C.; O'connor, A.A.; Nayak, S.K. 2001: IL-10 and IL-2 levels in melanoma patients undergoing immunotherapy with vaccines derived from autologous tumor cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 42: 684

Bober, L.A.; Rojas Triana, A.; Jackson, J.V.; Leach, M.W.; Manfra, D.; Narula, S.; Grace, M. 2001: IL-10 and IL-4 have regulatory effects on human neutrophil function ex vivo and in a rat model of arthritis. FASEB Journal 15(4): A356

Patke, C.L.; Shearer, W.T. 2001: IL-10 and SDF-1alpha modulate HIV-1 gp120 induced alterations in B cell function Proliferation, Ig production, surface antigen expression and apoptosis. Journal of Allergy and Clinical Immunology 107(2): S138

Jutel, M.; Akdis, M.; Budak, F.; Malolepszy, J.; Casaulta, C.; Wrzyszcz, M.; Blaser, K.; Akdis, C.A. 2001: IL-10 and TGF-beta cooperate in inducing peripheral T cell tolerance during specific immunotherapy with inhalant allergens and during natural allergen exposure. Journal of Allergy and Clinical Immunology 107(2): S90

Chan, J.; Gonsalkorale, W.M.; Perrey, C.; Previca, V.; Hajeer, A.H.; Whorwell, P.J.; Hutchinson, I.V. 2000: IL-10 and TGF-beta genotypes in irritable bowel syndrome Evidence to support an inflammatory component?. Gastroenterology 118(4 Suppl 2 Pt 1): A184

Schroeder, M.; Meisel, C.; Buhl, K.; Sievert, N.; Profanter, N.; Volk, H.D.; Gruetz, G. 2003: IL-10 and TGF-beta have different mechansisms for inhibiting cytokine-induced IFN-gamma production. European Cytokine Network 14(Suppl 3): 63

Chen, Z.M.; Gramaglia, I.; O'shaughnessy, M.; Panoskaltsis Mortari, A.; Murphy, W.; Narula, K.; Moore, K.; Roncarolo, M.G.; Blazar, B.R. 2001: IL-10 and TGF-beta treated primary MLR A source of immune regulatory cells that inhibit alloresponses in vitro and suppress GVHD in vivo. FASEB Journal 15(4): A667

D.L., V.; Yang, P.C.; Berin, M.C.; Singh, P.; Perdue, M.H. 2000: IL-10 and TGFbeta correct IL-4 enhanced uptake of macromolecules by human colonic epithelium. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A822

Jutel, M.; Akdis, M.; Budak, F.; Malolepszy, J.; Casaulta, C.; Wrzyszcz, M.; Akdis, C.A.; Blaser, K. 2001: IL-10 and TGFbeta induce peripheral T cell tolerance during specific immunotherapy with inhalant allergens and natural allergen exposure. Allergy 56(Suppl 68): 91

John, C.C.; Sumba, P.O.; Ouma, J.H.; Nahlen, B.L.; King, C.L.; Kazura, J.W. 1999: IL-10 and TNF-alpha responses to Plasmodium falciparum liver-stage antigen-1 decrease in the dry season in a population in highland Kenya. American Journal of Tropical Medicine and Hygiene 61(3 Suppl): 487

Kaya, Z.; Dohmen, K.M.; Wang, Y.; Schlichting, J.; Afanasyeva, M.; Leuschner, F.; Rose, N.R. 2002: IL-10 and nasal tolerance in experimental autoimmune myocarditis. FASEB Journal 16(5): A1067

Carlin, J.M.; Telbis, V.P.; Freppon, D.A. 2001: IL-10 blocks cytokine production and inhibits indoleamine dioxygenase in chlamydia-infected macrophages. Journal of Interferon and Cytokine Research 24(Suppl 1): S 132

Asiedu, C.; Ray, P.D.; George, J.F.; Thomas, J.M. 2002: IL-10 but not IL-4 is critical for tolerance induced by peritransplant T cell depletion combined with 15-deoxyspergualin. FASEB Journal 16(5): A1031

Hashimoto, T.; Oshika, Y.; Yamazaki, H.; Nakamura, M.; Ueyama, Y.; Ota, H.; Minoguchi, K.; Adachi, M. 2000: IL-10 cDNA transfection relieves IFN-gamma effects in normal human lung fibroblast cells. Journal of Allergy and Clinical Immunology 105(1 part 2): S115

Marra, L.E.M.rra E.; Zhang, Z.X.; Levy, G.A.; Penninger, J.M.; Zhang, L. 2001: IL-10 can inhibit the function of antigen-specific regulatory T cells by enhancing their susceptibility to apoptosis. FASEB Journal 15(5): A1046

Trocha, S.D.; Caswell, J.; Grisham, M.B.; Lefer, D.J. 1999: IL-10 deficiency exacerbates myocardial ischemia-reperfusion injury. Circulation 100(18): I478-I479

Chmiel, J.F.; Konstan, M.W.; Krenicky, J.E.; Saadane, A.; Berger, M. 2001: IL-10 deficiency is associated with excessive and prolonged inflammation after endobronchial P aeruginosa infection and mimics cystic fibrosis. Pediatric Research 49(4 Part 2): 458A

Whary, M.T.; Fox, J.G. 2000: IL-10 deficiency reduces Helicobacter pylori colonization in C57BL/6 mice. Gut 47(Suppl 1): A36-A37

Whary, M.T.; Sheppard, B.J.; Cline, J.; Xu, S.; Fox, J.G. 2001: IL-10 deficiency reduces Helicobacter pylori gastric colonization in C57BL/6 mice. Gastroenterology 120(5 Suppl 1): A99-A100

Igietseme, J.U.; Lyn, D.; Ananaba, G.A.; Eko, F.O.; Bowers, S.; Moore, T.; Black, C.M. 2000: IL-10 deficient dendritic cells as cellular vaccines against Chlamydia trachomatis. Abstracts of the General Meeting of the American Society for Microbiology 100: 278

Murphy, M.L.; Wille, U.; Hunter, C.A.; Farrell, J.P. 1999: IL-10 deficient mice are resistant to Leishmania donovani infection. FASEB Journal 13(5 Part 2): A655

Kim, S.C.; Tonkonogy, S.L.; Balish, E.; Warner, T.; Sartor, R.B.lfour 2001: IL-10 deficient mice monoassociated with non-pathogenic Enterococcus faecalis develop chronic colitis. Gastroenterology 120(5 Suppl 1): A82-A83

Makkink, M.K.; Schwerbrock, N.M.J.; Maehler, M.; Wagner, S.; Cornberg, M.; Einerhand, A.W.C.; Bueller, H.A.; Hedrich, H.J.; Enss, M.L.; Dekker, J. 2000: IL-10 deficient mice show highly specific changes in epithelial gene expression during colitis. JPGN 31(Suppl 2): S275

Lundberg, A.H.; Zheng, X.X.; Strom, T.; Gaber, O. 2001: IL-10 fusion protein reduces pulmonary ICAM-1 expression and injury in diet induced pancreatitis in mice. Gastroenterology 120(5 Suppl 1): A 348

Huang, Y.; Xia, J.; Yang, C.; Ye, S.; Ye, Y. 2002: IL-10 gene expression and cardiac allograft survival with or without treatment of monoclonal antibodies, CsA, donor-specific transfusion after rat heart transplantation. Journal of Heart and Lung Transplantation 21(1): 129

Roh, E.Y.; Park, M.H.; Park, H.J.; Ha, J.; Kim, S.J. 2002: IL-10 gene polymorphism in Koreans and its effect on renal allograft rejection. Human Immunology 63(Suppl 1): S66

Wallace, G.R.; Chen, Y.; Vaughan, R.W.; Kondeatis, E.; Graham, E.M.; Fortune, F.; Stanford, M.R. 2003: IL-10 gene polymorphisms associate with Behcets disease, but not retinal vasculitis. Inflammation Research 52(Suppl 2): S 91

Lindsay, J.O.; Van Montfrans, C.; Te Velde, A.A.; Brennan, F.M.; Hodgson, H.J.F.; Pena, M.S. Rodriguez 2002: IL-10 gene therapy ameliorates TNBS induced colitis. Gut 50(Suppl 2): A14

Carmody, E.E.; Puzas, J.E.; Rosier, R.N.; O'keefe, R.J.; Schwarz, E.M. 2001: IL-10 gene therapy inhibits inflammatory bone resorption. Journal of Bone and Mineral Research 16(Suppl 1): S199

Dharancy, S.; Leteurtre, E.; Gambiez, L.; Canva, V.; Pruvot, F.R.; Paris, J.C.; Desreumaux, P. 2000: IL-10 hepatic deficit in hepatitis C virus infection. Gastroenterology 118(4 Suppl 2 Pt 1): AASLD A944

Zheng, H.X.; Burckart, G.J.; Mccurry, K.; Webber, S.; Zaldonis, D.; Ristich, J.; Iacono, A.; Dauber, J.; Grgurich, W.; Mcdade, K.; Zeevi, A. 2003: IL-10 high genotype is protective against acute persistent rejection after lung transplantation. Journal of Heart and Lung Transplantation 22(1S): S77-S78

Toto, P.; Feliciani, C.; Amerio, P.; Suzuki, H.; Shivji, G.; Wang, B.; Altun, V.B.; Woodley, D.; Sauder, D. 1999: IL-10 immunomodulation in treatment of pemphigus. Journal of Investigative Dermatology 112(4): 614

Minohara, Y.; Fan, X.J.; Hawkins, H.K.; Crowe, S.E.; Patel, J.A.; Ernst, P.B. 1999: IL-10 impairs binding and induction of apoptosis by Helicobacter pylori. Immunology Letters 69(1): 53

Battaglia, M.; Gregori, S.; Stabilini, A.; Draghici, E.; Davalli, A.; Bonifacio, E.; Roncarolo, M.G.azia 2002: IL-10 in Combination with a Steroid-Free Immunosuppression Prevents Allogeneic beta-Islet Rejection and Induces Tr1 Cells In Vivo. Blood 100(11): Abstract No. 2405

Schuette, A.W.; Dempster, A.M.; Rees, A.J.; Erwig, L.P.ter 2001: IL-10 induced programmed upregulation of chemokine receptors on human monocytes translates into an increased migratory response to chemokines. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 662A

Eigenmann, P.A.; Tropia, L.; Hauser, C.; Frossard, C.P. 2003: IL-10 induces antigen-specific T-cell anergy but no regulatory T cells in children with egg allergy. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S106-S107

Gleissner, C.; Zastrow, A.; Klingenberg, R.; Xia, N.; Dengler, T.J. 2003: IL-10 induces suppressor of cytokine secretion-3 and ILT-3 in human endothelial cells and inhibits T cell costimulation. Journal of Heart and Lung Transplantation 22(1S): S81

Ding, Y.; Qin, L.; Su, R.; Bromberg, J.S. 2002: IL-10 inhibits IFNgamma and autoregulates IL-10 signaling through SOCSs. FASEB Journal 16(4): A313-A314

Kanwar, S.; Mendoza, L.; Manna, S.K.; Aggarwal, B.B.; Smith, C.W. 2000: IL-10 inhibits IL-1-mediated endothelial cell activation. FASEB Journal 14(4): A273

Schottelius, A.J.; Mayo, M.W.; Sartor, R.B.; Baldwin, A.S.Jr 1999: IL-10 inhibits NF-kappaB through distinct mechanisms. Immunology Letters 69(1): 76-77

Gleissner, C.A.; Zastrow, A.; Klingenberg, R.; Xia, N.; Dengler, T.J. 2003: IL-10 inhibits T cell costimulation and induces suppressor of cytokine secretion 3 and ILT3 in human endothelial cells. Circulation 108(17): IV281

Kanwar, S.; Smith, C.W.yne 2001: IL-10 inhibits TNF-alpha-induced leukocyte recruitment in vivo. FASEB Journal 15(4): A337

Wong, B.; Cates, E.; Conway, M.; Dalrymple, A.; Goncharova, S.; Stampfli, M.; Sun, J.; Waserman, S.; Jordana, M. 2003: IL-10 inhibits allergen-specific Th2 chemokine production but not chemokine receptor expression by human peripheral blood mononuclear cells in ragweed allergic subjects. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S285

Sun, J.; Goncharova, S.; Conway, M.; Dalrymple, A.; Cates, E.C.; Stampfli, M.R.; Wong, B.; Waserman, S.; Jordana, M. 2002: IL-10 inhibits allergen-specific Th2 cytokine production by human peripheral blood mononuclear cells from patients with ragweed allergies. Journal of Allergy and Clinical Immunology 109(1 Suppl): S66

Zhou, J.H.; Tang, Q.; Broussard, S.R.; Shen, W.H.; Vanhoy, R.W.; Kelley, K.W. 2000: IL-10 inhibits apoptosis of promyeloid cells. FASEB Journal 14(6): A1090

Dengler, T.J.; Klingenberg, R.; Zastrow, A.; Koenig, H.; Xia, N.; Haass, M. 2002: IL-10 inhibits endothelial-induced T cell activation through effects upon costimulation but independent of antigen presentation. Journal of Heart and Lung Transplantation 21(1): 123

Hamilton, T.A.; Dai, Y.; Novotny, M.; Tebo, J.; Dasgupta, J. 2001: IL-10 inhibits inflammatory chemokine expression both transcriptionally and post-transcriptionally. Journal of Interferon and Cytokine Research 24(Suppl 1): S 60

Gillespie, S.R.; Mirmonsef, P.; Yeatman, C.F.; Chong, H.J.; Shelburne, C.P.; Ryan, J.J. 1999: IL-10 inhibits mouse mast cell FcEpsilonRI expression. FASEB Journal 13(4 Part 1): A323

Krulová, M.; Kuffová, L.; Zajícová, A.; Filipec, M.; Holán, V. 1999: IL-10 is an effector molecule mediating urocanic acid-induced immunosuppression. Transplantation Proceedings 31(1-2): 1218-1219

Juedes, A.; Rodrigo, E.; Bot, A.; Bot, S.; Von Herrath, M.G. 2003: IL-10 is required for induction but not effector functions of autoreactive , IL-4 dependent regulatory cells. FASEB Journal 17(7): C274

Pollak, R.D.; Gelb, N.; Rachmilewitz, D.; Karmeli, F.; Weinreb, M. 2002: IL-10 knockout mice develop reduced bone formation, osteopenia and mechanical fragility. Journal of Bone and Mineral Research 17(Suppl 1): S190

Anaya, J.M.; Eskdale, J.; Correa, P.A.; Mantilla, R.D.; Gallagher, G. 1999: IL-10 microsatellite polymorphisms in primary Sjogrens syndrome. Arthritis and Rheumatism 42(9 Suppl): S137

Wang, X.N.; Oliver, K.M.; Jackson, G.H.; Proctor, S.J.; Dickinson, A.M. 2000: IL-10 modulation of graft-versus-host reaction. Human Immunology 61(Suppl 1): S141

Kotake, Y.; Sang, H.; Tabatabaie, T.; Moore, D.R.; Wallis, G.L.; Stewart, C.A. 2000: IL-10 over-expression is causal in PBNs protection from acute inflammation. Free Radical Biology and Medicine 29(Suppl 1): S58

Niikura, M.; Kamiya, S.; Nakane, A.; Kita, K.; Kobayashi, F. 2010: IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites. International Journal for Parasitology 40(1): 101-108

Van Der Sluijs, K.F.; Van Elden, L.; Nijhuis, M.; Schuurman, R.; Jansen, H.M.; Lutter, R.; Van Der Poll, T. 2003: IL-10 plays a major role in the enhanced susceptibility to pneumococcal pneumonia in mice recovered from influenza a infection. European Cytokine Network 14(Suppl 3): 70

Karabon, L.; Swider, C.; Lange, A. 2001: IL-10 polymorphic features were associated with the outcome of hematopoietic stem cell transplantation. European Journal of Immunogenetics 28(2): 236

Lio, D.; Scola, L.; Crivello, A.; Candore, G.; Colonna Romano, G.; Chiappelli, M.; Tampieri, C.; Licastro, F.; Branzi, A.; Caruso, M.; Hoffmann, E.; Caruso 2003: IL-10 polymorphisms in patients affected by acute myocardial infarction. Genes and Immunity 4(Suppl 1): S35

Boussiotis, V.A.; Delgado, J.C.; Thim, S.; Tsai, E.Y.; Baena, A.; Dascher, C.C.; Berezovskaya, A.; Rousset, D.; Reynes, J.M.; Grosjean, P.; Yunis, E.J.; Goldfeld, A.E. 2000: IL-10 producing T cells suppress immune responses in tuberculosis patients anergic to PPD. Tubercle and Lung Disease 80(6): 287

Emilie, D.; Llorente, L.; Richaud Patin, Y.; Couderc, J.; Galanaud, P.; Alarcon Segovia, D. 1999: IL-10 production by B lymphocytes in SLE Is it a marker of B1 lymphocyte dysregulation?. Journal of Autoimmunity (Suppl ): 9

Semper, A.E.; Libri, N.; Sanders, E.; Rosenberg, W.M. 2002: IL-10 production by Dendritic Cells is enhanced by cross linking the HCV receptor CD81. Hepatology 36(4 Part 2): 266A

Layton, G.T.; Ward, G. 2001: IL-10 production by human monocytes is serum dependant. Inflammation Research 50(Suppl 3): S217

Wright, A.; Tessa, R.; Lohman, I.C.; Halonen, M.; Martinez, F.D. 2002: IL-10 production early in life predicts recurrent wheezing in infancy. Journal of Allergy and Clinical Immunology 109(1 Suppl): S364

Hepkema, B.G.; Kouprie, N.; Van Dijk, E.; Ploeg, R.J.; De Leij, L.F.M.H.; Van Son, W.J.; Tegzess, A.M.; Lems, S.P.M. 1999: IL-10 promoter genotype and pregnancy induced HLA-antibodies. Human Immunology 60(Suppl 1): S75

Zhong, J.; Deaciuc, I.V.; Burikhanov, R.; Deilliers, W.J.S.V. 2003: IL-10 protects against LPS-induced liver injury by decreasing pro-inflammatory cytokines and apoptosis. FASEB Journal 17(4-5): Abstract 162

Gasche, C.; Reinisch, W.; Shaw, S.H.; Zdanov, A. 2002: IL-10 receptor alpha single nucleotide polymorphisms and response to IL-10 therapy in Crohns disease. Gastroenterology 122(4 Suppl 1): A-145

Mathurin, P.; Miyahara, T.; Motomura, K.; Tsukamoto, H. 1999: IL-10 receptor and co-receptor expression in quiescent and activated hepatic stellate cells. Hepatology 30(4 Part 2): 488A

Walker, S.O.; Kolostyak, K.P.; Wu, D.Y.; Ross Cisneros, F.N.; Sadun, A.A. 2001: IL-10 receptor localization on naive retinal ganglion cells Implications for neuroprotection against cytokine-induced apoptosis. IOVS Investigative Ophthalmology and Visual Science 42(4): S750

Jung, M.; Schuett, S.; Kraetzschmar, J.; Sabat, R.; Asadullah, K.; Doecke, W.; Volk, H.D.; Gruetz, G. 2002: IL-10 regulated genes in human monocytes. Journal of Interferon and Cytokine Research 22(Suppl 1): S-188

Justice, J.P.; Shibata, Y.; Van Scott, M.R. 1999: IL-10 regulates the level of GATA-3 in cytoplasm of TH2 cells. FASEB Journal 13(4 Part 1): A366

Froen, J.F.; Munkeby, B.H.; Stray Pedersen, B.; Saugstad, O.D. 2002: IL-10 reverses detrimental effects of endotoxin on hypoxic-lschemic perinatal brain injury in piglets. Pediatric Research 51(4 Part 2): 441A-442A

Doherty, J.M.; Mellon, J.; Streilein, J.W. 2001: IL-10 secretion by corneal endothelial cells is enhanced by exposure to inflammatory macrophages. IOVS Investigative Ophthalmology and Visual Science 42(4): S472

Alscher, D.M.; Pauli Magnus, C.; Kuhlmann, U.; Mettang, T. 1999: IL-10 secretion of lymphocytes is influenced by the mode of dialysis in end stage renal disease patients. Kidney and Blood Pressure Research 22(4-6): 211

Stelmach, I.; Jerzynska, J.; Stelmach, W.; Majak, P.; Grzelewski, T.; Kuna, P. 2003: IL-10 serum levels in children with moderate atopic asthma. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S179

Gomez Quiroz, L.; Kershenobich, D.; Gutierrez Ruiz, C. 2002: IL-10 stimulates IL-8 secretion in acetaldehyde-treated HepG2 cells. Journal of Hepatology 36(Suppl 1): 210-211

Asadullah, K.; Friedrich, M.; Doecke, W.; Hanneken, S.; Rohrbach, C.; Audring, H.; Volk, H.; Sterry, W. 2001: IL-10 therapy in psoriasis Effects on the skin immune system. Journal of Investigative Dermatology 117(2): 546

Doecke, W.; Friedrich, M.; Belbe, G.; Ebeling, M.; Volk, H.; Sterry, W.; Asadullah, K. 2001: IL-10 therapy in psoriasis Systemic immunological effects. Journal of Investigative Dermatology 117(2): 546

Hayamizu, K.; Shinozaki, K.; Fan, X.; Yahata, H.; Tashiro, H.; Asahara, T. 2001: IL-10 transduction of liver allografts induces antiinflammatory monocytes in long-term-surviving hosts. Transplantation Proceedings 33(1-2): 355

Kitching, A.R.; Tipping, P.G.; Power, D.A.; Katerelos, M.; Holdsworth, S.R. 1999: IL-10 treatment of experimental mesangial proliferative glomerulonephritis reduces glomerular inflammatory cell recruitment and cellular proliferation. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 514A-515A

Downs, A.; Erber, W. 1999: IL-10 up-regulates CD14 and Fcgamma receptors on monocytes in vitro. British Journal of Haematology 105(Suppl 1): 55

Na, K.S.; Kang, T.Y.; Yoo, D.H. 2003: IL-10 up-regulates MCP-1 from IFN-gamma stimulated human mesangial cells. Inflammation Research 52(Suppl 2): S 149

Picchioni Bompeixe, E.; Von Linsingen, R.; Bicalho, M.D.G.aca 2003: IL-10, TNF-alpha and IFN-gamma gene polymorphisms and recurrent spontaneous abortion. Human Immunology 64(Suppl 1): S172

Chan, J.; Gonsalkorale, W.M.; Mani, V.; Hajeer, A.H.; Whorwell, P.J.; Perrey, C.; Previca, V.; Hutchinson, I.V. 2000: IL-10, TNF-alpha and TGF-beta genotypes A role in susceptibility to ulcerative colitis?. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A332

Bettelli, E.; Nicholson, L.B.; Kuchroo, V.K. 2003: IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. Journal of Autoimmunity 20(4): 265-267

Lee, J.G.; Ahn, C.; Lim, C.S.; Han, J.S.; Kim, S.; Lee, J.S. 1999: IL-10, but not other cytokines is elevated in hemorrhagic fever with renal syndrome. Nephrology Dialysis Transplantation 14(9): A75

Hauben, E.; Schulz, U.; Bacchetta, R.; Gregori, S.; Tresoldi, E.; Roncarolo, M.G. 2004: IL-10-dependent Induction of a new subset of Tolerogenic Antigen Presenting Cells. FASEB Journal 18(4-5): Abstract 91

Mills, Kingston H.G.; Mcguirk, Peter; Higgins, Sarah; Mccann, Chantelle; Leavy, Olive; Brady, Miriam; Mc Neela, Edel; Keogh, Brian; Lavelle, Ed 2003: IL-10-secreting regulatory T cells Their induction and role in infection. European Cytokine Network 14(Suppl 3): 131

Steinbrink, K.; Kubsch, S.; Graulich, E.; Tueting, T.; Knop, J.; Enk, A. 2001: IL-10-treated human dendritic cells induce anergic CD4+ and CD8+ T cells with antigen-specific suppressor activity. Journal of Investigative Dermatology 117(2): 446

Min, W.; Hu, Y.; Mark, S. 1999: IL-10/IL-10 receptor activation of a LIM-only signal molecule regulating tissue inhibitor of matrix metalloproteinase-1 expression and metastasis. Proceedings of the American Association for Cancer Research Annual Meeting 40: 198

Rico, M.J.; Matar, P.; Scharovsky, O.G. 2002: IL-10/IL-10R differential expression in primary tumor and metastatic cells of a rat B cell lymphoma. Proceedings of the American Association for Cancer Research Annual Meeting 43: 438-439

Feliciani, C.; Toto, P.; Amerio, P.; Pour, S.M.; Coscione, G.; Shivji, G.; Wang, B.; Sauder, D.N. 1999: IL-101alpha and TNF-01alpha are the main cytokines involved in acantholysis. Journal of Investigative Dermatology 112(4): 614

Mahboubi, K.; Biedermann, B.C.; Dengler, T.J.; Carroll, J.; Pober, J.S. 1999: IL-11 activates human endothelial cells to resist immune-mediated injury but not oxidative injury. FASEB Journal 13(5 Part 2): A854

Morrissey, J.J.; Moridaira, K.; Guo, G.; Klahr, S. 2002: IL-11 ameliorates tubulointerstitial fibrosis. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 552A

Trepicchio, W.; Ozawa, M.; Walters, I.B.; Kikuchi, T.; Schwertschlag, U.; Dorner, A.; Krueger, J.G. 1999: IL-11 is an immune-modulatory cytokine which downregulates IL-12, type 1 cytokines, and multiple inflammation-associated genes in patients with psoriasis. Journal of Investigative Dermatology 112(4): 598

Kiessling, S.; Mueller Newen, G.; Blanc, C.; Wachs, F.P.; Weger, L.; Schoelmerich, J.; Montero, F.A.; Andus, T.; Heinrich, P.C.; Rogler, G. 2000: IL-11 receptor is mainly expressed on epithelial cells in normal colonic mucosa. Gastroenterology 118(4 Suppl 2 Pt 1): A97

Cairo, Mitchell S.; Ayello, Janet; Suri, Mandhir; Wu, Jie; Lillianthal, Shaun; De Ven, Carmella Van 2002: IL-12 + IL-18 Significantly Enhances CB NK and LAK Cytotoxicity but Is Significantly Inferior Compared to IL-12 + IL-18 Induced APB NK + LAK Cytoxicity Implications for Differential Immune Reconstitution and/or Graft-vs-Tumor Effect Post UCBT. Blood 100(11): Abstract No. 2427

Hoffman, P.S.; Vats, N.; Hutchinson, D.; Van Zanten, S.V.; Marshall, J.S. 2001: IL-12 KO mouse is highly permissive to infection by Helicobacter pylori. IJMM International Journal of Medical Microbiology 291(Suppl 31): 136-137

Cleary, A.M.; Tu, W.; Malefyt, R.D.W.al; Lewis, D.B. 2002: IL-12 Receptor beta1 Deficiency Insights into Memory CD4 T Cell Generation/Maintenance and Receptor Expression. Blood 100(11): Abstract No. 705

Metzger, D.W.; Arulanandam, B.P. 1999: IL-12 Stimulation of Neonatal immunity. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)

Spadaro, M.; Quaglino, E.; Curcio, C.; Anton, I.; Forni, G.; Amici, A.; Iezzi, M.; Rovero, S.; Cavallo, F. 2002: IL-12 activated immunity in the prevention of mammary carcinogenesis in Her-2/neu transgenic mice. Journal of Interferon and Cytokine Research 22(Suppl 1): S-64-S-65

Pirtskhalaishvili, G.; Gambotto, A.; Esche, C.; Yurkovetsky, Z.R.; Lotze, M.T.; Shurin, M.R. 2000: IL-12 and Bcl-xL gene transfection of murine dendritic cells protects them from prostate cancer-induced apoptosis and improves their antitumor activity. Journal of Urology 163(4 Suppl): 105

Bost, K.L.; Bento, J.L.; Marriott, I.; Hudson, M.C. 2000: IL-12 and GM-CSF expression by bacterially infected osteoblasts. FASEB Journal 14(6): A1059

Jouanguy, E.; Döffinger, R.; Dupuis, S.; Pallier, A.; Altare, F.; Casanova, J.L. 1999: IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Current Opinion in Immunology 11(3): 346-351

Ozkan, T.; Budak, F.; Meral, A.; Gocet, N.; Goral, G.; Ozeke, T. 2000: IL-12 and IFN-gamma levels in children with chronic hepatitis B receiving IFN therapy. JPGN 31(Suppl 2): S52

Ohnishi, C.; Takehara, T.; Suzuki, T.; Jinushi, M.; Miyagi, T.; Tatsumi, T.; Hiramatsu, N.; Kanto, T.; Hayashi, N. 2003: IL-12 and IFNalpha gene therapy for hepatic metastasis of colon cancer Difference in generation of innate and adaptive immune responses. Hepatology 38(4 Suppl 1): 582A

Harris, P.; Arenillas, S.; Godoy, A.; Pena, A.; Rollan, A.; Duarte, I.; Guiraldes, E. 2001: IL-12 and IL-10 expression in gastric mucosa of Helicobacter pylori-infected children. JPGN Journal of Pediatric Gastroenterology and Nutrition 32(3): 358

Butts, C.L.; Savary, C.A.; Vadhan Raj, S.; Freedman, R.S. 2002: IL-12 and IL-10 production in dendritic cell cultures from peritoneal exudate cells and peripheral blood mononuclear cells of patients with epithelial ovarian cancer following treatment in vitro with soluble CD40 ligand. Proceedings of the American Association for Cancer Research Annual Meeting 43: 973

Ferrini, Silvano; Comes, Alberto; Croce, Michela; Rosso, Ombretta; Di Carlo, Emma; Musiani, Piero; Orengo, Anna Maria 2002: IL-12 and IL-15 gene transfer cooperate to induce tumor rejection and protective antibody responses in T cell deficient mice. Proceedings of the American Association for Cancer Research Annual Meeting 43: 437-438

Ferrone, C.R.; Perales, M.A.; Wolchok, J.D.; Ramirez Montagut, T.; Gregor, P.; Fantuzzi, G.; Houghton, A.N. 2001: IL-12 and IL-18 DNA Molecular adjuvants for antitumor vaccines. Journal of Leukocyte Biology Suppl: 89

Paulukat, J.; Nold, M.; Ninic, R.; Bosmann, M.; Pfeilschifter, J.; Muehl, H. 2002: IL-12 and IL-18 activated PBMC mediate expression of IL-18 binding protein and iNOS in adjacent DLD-1 colon carcinoma/epithelial cells. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R73

Shigehara, K.; Shijubo, N.; Ohmichi, M.; Takahashi, R.; Kon, S.; Okamura, H.; Kurimoto, M.; Hiraga, Y.; Tatsuno, T.; Abe, S.; Sato, N. 2001: IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. Journal of Immunology 166(1): 642-649

Pollard, R.B.; Kobayashi, M.; Wolf, S.E.; Herndon, D.N.; Suzuki, F. 2001: IL-12 and IL-18 in combination improve the impaired production of MIP-1alpha by T cells from thermally injured mice. FASEB Journal 15(4): A346

Qureshi, M.H.; Kawakami, K.; Koguchi, Y.; Zhang, T.; Kurimoto, M.; Saito, A. 1999: IL-12 and IL-18-induced fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans also involves TNF-alpha. Abstracts of the General Meeting of the American Society for Microbiology 99: 289

Fol, M.; Szeliga, J.; Goscicka, T. 2000: IL-12 and Listeria effect in vitro on the IL-6, TNFalfa and no production by C57BL/6 mouse peritoneal exudate macrophages. Immunology Letters 73(2-3): 114

MacDonald, T.T.; Monteleone, G. 2001: IL-12 and Th1 immune responses in human Peyer's patches. Trends in Immunology 22(5): 244-247

Muller Berghaus, J.; Kierstaed, L.S.; Ranieri, E.; Storkus, W.J. 2000: IL-12 and human monocyte-derived DC Production and phenotype. FASEB Journal 14(6): A1050

Santos, W.R.; Paraguai, D.S.uza, E.; Soares Machado, F.C.; Aguiar, I.A.; Palatnik, M.; Palatnik, D.S.usa, C.B. 2000: IL-12 and saponin as adjuvants in the formulation of FML-vaccine against experimental visceral leishmaniasis in mice. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 162

Campbell, I.L. 2000: IL-12 and type 1 cell-mediated immunity in the CNS. Immunology 101(Suppl 1): 51

Zhang, S.; Gu, J.; Kao, C.; Gardner, T.; Eble, J.N.; Cheng, L. 2001: IL-12 antitumor effect is mediated by Fas-Fas ligand induced apoptosis. Laboratory Investigation 81(1): 131A

Pollard, R.B.; Kobayashi, M.; Kobayashi, H.; Herndon, D.N.; Suzuki, F. 1999: IL-12 combined with benzoylmesaconine, a non-toxic aconitine-hydrolysate, improves the resistance of burned mice severely infected with herpes simplex virus type 1. FASEB Journal 13(4 Part 1): A640

Werth, V.; Zhang, W. 2001: IL-12 completely blocks the secretion of TNFalpha from cultured skin cells Implications for photosensitive conditions. Journal of Investigative Dermatology 117(2): 498

Metzger, D.W.; Buchanan, R.M. 2001: IL-12 enhancement of immune responses to T-independent antigens. Official Gazette of the United States Patent and Trademark Office Patents 1251(3)

Hall, S.J.; Hassen, W.A.; Sanford, M.A.; Atkinson, G.; Chen, S.H. 1999: IL-12 enhances HSV-tk+GCV-induced natural killer cell activity in an orthotopic model of mouse prostate cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 631

Knutson, K.L.; Disis, M.L. 2000: IL-12 enhances in vitro expansion and function of peptide-specific T lymphocytes. Proceedings of the American Association for Cancer Research Annual Meeting 41: 193

Matsuse, H.; Hu, X.; Lockey, R.F.; Wolf, S.; Mohapatra, S.S. 1999: IL-12 enhances the shift from Th2- to Th1-like response in mouse model of grass allergy. Journal of Allergy and Clinical Immunology 103(1 Part 2): S48

Houldsworth, A.; Metzner, M.; Rossol, S.; Kaminski, E.; Demaine, A.G.; Cramp, M.E. 2003: IL-12 gene polymorphism and outcome of HCV infection. Hepatology 38(4 Suppl 1): 356A

Melero, I.; Mazzolini, G.; Narvaiza, I.; Qian, C.; Chen, L.; Prieto, J. 2001: IL-12 gene therapy for cancer: in synergy with other immunotherapies. Trends in Immunology 22(3): 113-115

Rakhmilevich, A.L.; Yang, N.S.n 1999: IL-12 gene therapy of tumors. Official Gazette of the United States Patent and Trademark Office Patents 1224(2)

Stroehlein, M.A.; Gruetzner, K.U.; Schildberg, F.W.; Heiss, M.M. 1999: IL-12 generated immune activity in gastrointestinal tumor patients Evidence for intrinsic capacity against autologous tumor cells. European Journal of Cancer 35(Suppl 5): S16

Herndon, B.; Latcham, S.; Bamberger, D. 2001: IL-12 increase during neutropenia in established infections. Journal of Leukocyte Biology Suppl: 69

Lieberman, L.A.; Cardillo, F.; Rennick, D.; Hunter, C.A. 2002: IL-12 independent mechanisms of resistance during T gondii infection A role for IL-23?. FASEB Journal 16(5): A1068

Stine, K.C.; Warren, B.; Saylors, R.L.; Becton, D.L. 2002: IL-12 induces IL-12 receptor expression on sensitive AML cell lines. Pediatric Research 51(4 Part 2): 233A

Stine, K.C.; Warren, B.A.; Becton, D.L. 2002: IL-12 induces IL-12 receptor up-regulation in Ewings Sarcoma cell lines prior to apoptosis. Pediatric Research 51(4 Part 2): 234A

Fan, H.; Tackey, R.; Dunston, G.M.; Walters, C.S. 2001: IL-12 induces T cell apoptosis in the absence of antigen. FASEB Journal 15(4): A706

Neumann, D.; Martin, M.U. 2000: IL-12 induces expression of the IL-18Rbeta chain in thymocytes of BALB/c mice. Immunobiology 203(1-2): 144

Kobayashi, I.; Muso, E.; Kusano, H.; Nogaki, F.; Miyawaki, S.; Yoshida, H.; Sasayama, S. 2000: IL-12 induces the chemicophysical change of serum and glomerular IgA in a high IgA strain of ddY mice. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 476A

Rizzo, L.V.; Figueiredo, F. 1999: IL-12 inhibition of endotoxin-induced uveitis is dependent on IFN-gamma. FASEB Journal 13(5 Part 2): A667

Roberts, R.L.; Choi, S.S.; Nguyen, O.H.; Ank, B.J.; Stiehm, E.R. 2000: IL-12 inhibits ANK activity and NK receptor expression when combined with IL-15. FASEB Journal 14(6): A1026

Choi, S.S.; Nguyen, Q.H.; Roberts, R.L.; Stiehm, E.R. 2000: IL-12 inhibits cytotoxicity and CD16/56 expression in long-term culture. Journal of Investigative Medicine 48(1): 74A

Rais, M.; Alam, R.; Wild, J.S.; Choudhury, B.K.; Stafford, S.; Sur, S. 1999: IL-12 inhibits differentiation of eosinophils from stem cells in an IFN-gamma-dependent manner. Journal of Allergy and Clinical Immunology 103(1 Part 2): S191

Rudner, X.; Barrett, R.; Lighvani, S.; Mcclellan, S.; Hazlett, L. 2001: IL-12 is capable of, but not necessary, to drive IFN-gamma production and susceptibility to P aeruginosa ocular infection. IOVS Investigative Ophthalmology and Visual Science 42(4): S514

Magone, M.T.; Whitcup, S.M.; Chan, C.C.; Silver, P.B.; Rizzo, L.V. 1999: IL-12 is essential for the induction of late phase cellular infiltration in a murine model of allergic conjunctivitis. IOVS Investigative Ophthalmology and Visual Science 40(4): S770

Magone, M.T.; Whitcup, S.M.; Chan, C.C.; Silver, P.B.; Rizzo, L.V. 1999: IL-12 is essential for the induction of the late phase cellular infiltration in a murine model of allergic conjunctivitis. FASEB Journal 13(4 Part 1): A338

Joo, Y.S.; Lee, S.S.; Kim, W.U.; Min, J.K.; Hong, Y.S.; Park, S.H.; Lee, S.H.; Cho, C.S.; Kim, H.Y. 1999: IL-12 is involved in bone metabolism of premenopausal rheumatoid arthritis patients and predicts bone loss. Arthritis and Rheumatism 42(9 Suppl): S354

Wu, C.Y.; Kirman, J.; Rotte, M.; Rhee, E.G.; Davey, D.; Freidag, B.; Seder, R.A. 2002: IL-12 is not essential to sustain memory Th1 cells in vivo. FASEB Journal 16(4): A330

Kong, X.; Matsuse, H.; Hu, J.; Wolf, S.; Lockey, R.F.; Mohapatra, S.S. 2000: IL-12 mediated Th2 to Th1 shift in a murine model of grass allergy is associated with differential IL-12 receptor expression. Journal of Allergy and Clinical Immunology 105(1 part 2): S180

Nakajima, T.; Abbas, A.E.; Schultz, S.; Warrington, K.J.; Kopecky, S.L.; Frye, R.L.; Goronzy, J.J.; Weyand, C.M. 2002: IL-12 mediated activation of cytotoxic CD4 T cells in acute coronary syndromes. Journal of the American College of Cardiology 39(5 Suppl A): 263A

Cain, J.A.; Deepe, G.S.Jr 1999: IL-12 neutralization during Histoplasma capsulatum infection alters effector cell phenotype. FASEB Journal 13(5 Part 2): A973

Coughlin, C.M.; Chehimi, J.; Marshall, J.D.; Chehimi, S.; Greene, J.; Starr, S.E.; Sullivan, K.E. 1999: IL-12 overproduction in hyper IgE syndrome. FASEB Journal 13(5 Part 2): A648

Wilder, J.; Sanchez, M.; Rardin, K.; Behrens, M.; Harrod, K. 2003: IL-12 p35-deficient mice fail to develop pulmonary Type 1 immunity to Cryptococcus neoformans. FASEB Journal 17(7): C196

Schneider, E.; Tonanny, M.B.; Leite, D.M.raies, M.; Dy, M. 2002: IL-12 plus IL-18 control peripheral histamine production by splenic basophil precursors through Fas-dependent apoptosis. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 53

Simmons, W.J.; Koneru, M.; Ponzio, N. 2002: IL-12 polarized Th1 cells promote development of SJL B cell lymphoma-specific cytotoxic effector cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1112

Xu, S.; Bedrosian, I.; Faries, M.; Roros, J.G.; Czerniecki, B.J. 2001: IL-12 production by CD83+ dendritic cells regulates development of anti-tumor reactive CD8+ T cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 22

Butts, C.L.; Templin, S.; Peng, C.; Freedman, R.S. 2000: IL-12 production by dendritic cells in the peritoneal cavity of patients with epithelial ovarian cancer following in vitro treatment with GM-CSF and IL-4. Proceedings of the American Association for Cancer Research Annual Meeting 41: 621

Hensmann, M.; Kwiatkowski, D.; Langhorne, J. 2000: IL-12 production by human peripheral blood mononuclear cells in response to Plasmodium falciparum infected erythrocytes. Immunology 101(Suppl 1): 92

Dianda, L.; Engwerda, C.; Kaye, P. 2000: IL-12 production by lymphoid and myeloid dendritic cell subsets in L donovani infection. Immunology 101(Suppl 1): 9

Liu, A.H.; Schiltz, A.M.; Thatayatikom, A.; Gereda, J.E.; Price, M.R.; Leung, D.Y.M.; Klinnert, M.D. 2002: IL-12 production in young children correlates with recent house-dust endotoxin exposure. Journal of Allergy and Clinical Immunology 109(1 Suppl): S276

Asari, A.; Kurihara, H.; Xu, H.; Miyauchi, S.; Minamisawa, T. 2002: IL-12 production inhibitor. Official Gazette of the United States Patent and Trademark Office Patents 1261(3)

Tada, Y.; Asahina, A.; Nakamura, K.; Miyazono, K.; Fujiwara, H.; Tamaki, K. 2000: IL-12 production of mouse Langerhans cells Regulation by GM-CSF and TGF-beta. Journal of Dermatological Science 23(3): 198

Tada, Y.; Asahina, A.; Nakamura, K.; Hachimura, S.; Kaminogawa, S.; Tamaki, K. 2001: IL-12 production of mouse Langerhans cells Regulation by TGF-beta for the induction of Th1 cells. Journal of Investigative Dermatology 117(4): 1022

Tada, Y.; Asahina, A.; Nakamura, K.; Tomura, M.; Fujiwarat, H.; Tamaki, K. 2000: IL-12 production of mouse Langerhans cells by CD40 ligation/IFN-gamma stimulation and its striking inhibition by granulocyte/macrophage colony stimulating factor. Journal of Investigative Dermatology 114(1): 223

Jain, A.; Fuss, I.; Strober, W. 2000: IL-12 protects T cells from FAS mediated apoptosis. FASEB Journal 14(6): A1090

Schwarz, A.; Staender, S.; Berneburg, M.; Grosse Heitmeyer, K.; Krutmann, J.; Schwarz, T. 2001: IL-12 protects from UV-induced apoptosis by accelerating DNA repair. Archives of Dermatological Research 293(1-2): 33

Schwarz, A.; Staender, S.; Berneburg, M.; Grosse Heitmeyer, K.; Krutmann, J.; Schwarz, T. 2001: IL-12 protects from UV-induced apoptosis by enhancing DNA repair. Journal of Investigative Dermatology 117(2): 494

Wu, C.Y.; Wang, X.; Presky, D.H.; Magram, J. 2000: IL-12 receptor beta 2 -deficient mice bind IL-12 but are defective in IL-12-mediated responses. FASEB Journal 14(6): A1182

Ireland, D.D.C.; Chesler, D.; Reiss, C.S. 1999: IL-12 receptor is present on murine CNS neurons. FASEB Journal 13(5 Part 2): A1144

Zhang, X.; Nakajima, T.; Goronzy, J.J.; Weyand, C.M. 2003: IL-12 regulates tissue-trafficking of CD4 T cells in rheumatoid arthritis. FASEB Journal 17(7): C270

Villinger, F.; Chikkala, N.F.; Brar, S.S.; Bucur, S.Z.; Lee, M.E.; Gillespie, T.W.; Adams, J.A.; Bostik, P.; Mayne, A.E.; Dailey, P.; Novembre, F.J.; Ansari, A.A.; Hillyer, C.D. 1999: IL-12 responses in vivo are lost during disease progression in SIV infected macaques. Journal of Medical Primatology 28(4-5): 280

Xu, S.; Koski, G.; Faries, M.; Bedrosian, I.; Mick, R.; Thomas, E.K.; Cheever, M.A.; Cohen, P.A.; Czerniecki, B.J. 2003: IL-12 secreting DC1 induces high functional avidity of tumor-recognizing CD8+ T cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 394

Mendel, I.; Shevach, E.M. 2002: IL-12 sensitizes autoreactive myelin oligodendrocyte glycoprotein -specific TCR transgenic T cells to activation induced cell death. FASEB Journal 16(5): A1059

Bosticardo, M.; Novelli, F.; Casanova, J.L.; Candotti, F. 2003: IL-12 signaling pathway is restored in IL-12 receptor beta-1 KO mice after retroviral-mediated gene transfer into hematopoietic stem cells. Blood 102(11): 492a

Stone, A.E.S.; Castleman, W.L. 2002: IL-12 treatment reduces the severity of Sendai virus-induced airway remodeling in brown Norway rats. FASEB Journal 16(4): A16

Suzuki, F.; Kobayashi, M.; Utsunomiya, T.; Herndon, D.N.; Pollard, R.B. 1999: IL-12 unresponsiveness due to CD8+ CD30+ burn-associated type 2 T cells in cultures of peripheral blood mononuclear cells from patients with large burn injuries. FASEB Journal 13(4 Part 1): A321

Roman, E.; Avello, J.; Wu, J.; Van, D.V.n, C.; Cairo, M.S. 2003: IL-12+IL-18 synergistically and additively enhances NK and LAK cytotoxicity in adult peripheral and cord blood , respectively Implications for adoptive cellular immunotherapy post allogeneic stem cell transplant. Pediatric Research 53(4 Part 2): 274A

Ehrhardt, R.O.; Hong, K.; Chu, A.; Ludviksson, B.R.; Berg, E.L. 1999: IL-12, but not IFN-gamma, plays a crucial role in the pathogenesis of murine psoriasis-like skin disorder. FASEB Journal 13(5 Part 2): A665

Jankovic, D.; Kullberg, M.C.; Hieny, S.; Caspar, P.; Collazo, C.M.; Sher, A. 2002: IL-12-independent development of host-protective Th1 cells. FASEB Journal 16(5): A1069

Simmons, W.J.; Koneru, M.; Ponzio, N.M. 2001: IL-12-induced effector cells inhibit growth of syngeneic B cell lymphomas of SJL/J mice. FASEB Journal 15(4): A659

Smits, H.H.; Van Rietschoten, J.G.I.; Hilkens, C.M.U.; Stiekema, F.; Kapsenberg, M.L.; Wierenga, E.A. 2001: IL-12-induced reversal of established human Th2 cells Restored IL-12 responsiveness and inverse GATA-3/T-bet ratio. Allergy 56(Suppl 68): 114

Warrington, K.J.; Vallejo, A.N.; Takemura, S.; Weyand, C.M.; Goronzy, J.J. 2001: IL-12-mediated rejuvenation of senescent T cells. FASEB Journal 15(4): A346

Michael, C.F.; Saeed, A.; Taner, I.H.; Du, X.; Park, Y.D.; Yang, J.; James, A.W.; Nair, U.; Fathman, G. 2003: IL-12-p40 gene transduced T cell hybridomas suppress the induction of collagen induced auricular chondritis in mice. FASEB Journal 17(4-5): Abstract 666

Martinez, I.; Israel, Z.; Villinger, F.; Sidhu, M.; Stout, R.; Montefiori, D.; O'neill, E.; Ansari, A.A.; Martnez, M.; Kraiselburd, E. 2002: Il-12/Gm-Csf Co-Administration with a Siv Vlp DNA Prime/Protein Boost Leads to Viral Control following Mucosal Siv Challenge in Rhesus Macaques. Journal of Medical Primatology 31(4-5): 269

Li, L.; Hsu, H.C.; Grizzle, W.E.; Zhang, H.G.; Mountz, J.D. 2002: IL-12b exerts an age-related regulatory effect on thymic involution at the earliest stage of T cell development. FASEB Journal 16(5): A1082-A1083

Li, L.; Hsu, H.C.; Grizzle, W.E.; Zhang, H.G.; Mountz, J.D. 2002: IL-12beta regulates age-related thymic involution. Journal of Investigative Medicine 50(1): 97A

Camoglio, L.; Juffermans, N.P.; Daalhuizen, J.B.; Kopf, M.; Van Deventer, S.H.J. 1999: IL-12p35 deficient mice develop a Th1 response during TNBS colitis. Immunology Letters 69(1): 116

Gran, B.; Zhang, G.X.; Yu, S.; Li, J.; Kamoun, M.; Rostami, A.M. 2003: IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis IL-12 is not required for the induction of inflammatory demyelination in the central nervous system. Neurology 60(5 Suppl 1): A217-A218

Fairweather, D.; Frisancho, S.; Yusung, S.; Barrett, M.; Steele, R.; Gatewood, S.; Rose, N.R. 2003: IL-12p40 protects against coxsackievirus-induced myocarditis and dilated cardiomyopathy by reducing IL-1 and IL-18 in the heart. FASEB Journal 17(7): C18

Wagner, M.; Poeck, H.; Jahrsdoerfer, B.; Rothenfusser, S.; Sarris, A.; Kerkmann, M.; Giese, T.; Endres, S.; Hartmann, G. 2003: IL-12p70 dependent Th1 induction by human B cells requires combined activation with CD40L and CpG DNA. FASEB Journal 17(7): C143

Mcdowell, M.A.; Marovich, M.A.; Sacks, D.L. 2000: IL-12p70 production in human dendritic cells by Leishmania spp is species and strain dependent. FASEB Journal 14(6): A952

Lehmann, J.; Bellmann, S.; Schroeder, R.; Haack, R.; Alber, G. 2000: IL-12p75-independent agonistic effects of IL-12p40 on the development of the type 1 immune response against Salmonella enteritidis. Immunobiology 203(1-2): 326

Ericksen, M.; Chen, W.; Hershey, G.K.K.urana 2003: IL-13 Q130 variant displays increased activity compared to wild type R130 IL-13. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S285

Collins, M.; Donaldson, D.; Fitz, L.; Neben, T.; Whitters, M.; Wood, C. 2001: IL-13 Receptor chain. Official Gazette of the United States Patent and Trademark Office Patents 1248(5)

Bonnefoy, J.Y.; Gauchat, J.F.CedillaOis 2000: IL-13 and IL-4 binding polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1240(1)

Deighton, J.; Ewan, P.W. 1999: IL-13 and not IL-4 regulates IgE production in hyper-IgE syndrome. Immunology 98(Suppl 1): 10

Webster, R.B.; Vercelli, D. 2002: IL-13 chromatin accessibility in human T cells. FASEB Journal 16(4): A693-A694

Webster, R.B.; Vercelli, D. 2003: IL-13 chromatin remodeling in differentiating human neonatal Th1 and Th2 cells. FASEB Journal 17(7): C103

Sun, J.; Papasavvas, E.; Bailer, R.; Moore, E.C.; Moonis, M.; Sutterwala, S.; Martin, M.; Minty, A.; Macgregor, R.R.; Kostman, J.R.; Montaner, L.J. 1999: IL-13 enhances antigen-presenting cell function and T-cell recall responses in vitro at all stages of HIV-1 infection. Journal of Leukocyte Biology (Suppl ): 13

Dekrey, G.K.; Bridges, J.; Notyce, D. 2002: IL-13 expression is increased by TCDD in Leishmania-infected mice. FASEB Journal 16(4): A579

Choudhry, S.; Lind, D.L.; Salari, K.; Ung, N.; Coyle, N.E.; Ziv, E.; Clark, S.L.; Nazario, S.; Rodriguez Santana, J.R.; Salas, J.; Selman, M.; Boushey, H.A.; Weiss, S.T.; Chapela, R.; Ford, J.G.; Rodriguez Cintron, W.; 2003: IL-13 gene sequence variants and haplotypes are associated with asthma, bronchodilator responsiveness and asthma severity in Mexicans and Puerto Ricans from the Genetics of Asthma in Latino Americans Study. American Journal of Human Genetics 73(5): 177

Atherton, H.C.; Jones, G.; Danahay, H. 2003: IL-13 induces a MAPK-dependent increase in goblet cell density in human bronchial epithelial cells. Inflammation Research 52(Suppl 2): S 83

Oriente, A.; Fedarko, N.S.; Pacocha, S.E.; Huang, S.K.; Lichtenstein, L.M.; Essayan, D.M. 1999: IL-13 induces collagen synthesis in normal and keloid fibroblasts. Journal of Allergy and Clinical Immunology 103(1 Part 2): S239

Xu, B.; Bhattacharjee, A.; Roy, B.; Xu, H.M.; Frank, D.A.; Feldman, G.M.; Cathcart, M.K. 2003: IL-13 induction of 15-lipoxygenase gene expression requires p38 MAPK-dependent serine phosphorylation of Stat1 and Stat3. FASEB Journal 17(4-5): Abstract 864

Roy, B.; Maizel, A.; Cathcart, M.K. 1999: IL-13 induction of 15-lipoxygenase in human monocytes Receptor components, Jaks and Stats. Circulation 100(18): 1; 428

Herrick, C.; Tigelaar, R.; Bottomly, K. 2001: IL-13 is required independently of IL-4 for epicutaneously induced Th2 responses to soluble protein. Journal of Investigative Dermatology 117(2): 453

Jakubzick, C.V.; Campbell, E.; Westwick, J.; Evanoff, H.; Hogaboam, C.; Kunkel, S. 2002: IL-13 modulates phenotypic profile of type 1 and type 2 fibroblasts. FASEB Journal 16(4): A595

Yasmin, T.; Malekgoudarzi, B.; Huang, C.Y.; Wang, S.; Frieri, M. 1999: IL-13 production by allergen-specific polymorphonuclear cells from asthmatic patients. Journal of Investigative Medicine 47(4): 214A

Puri, R.K.; Debinski, W.; Pastan, I.; Obiri, N. 1999: IL-13 receptor specific chimeric proteins. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)

Puri, R.K.; Debinski, W.; Pastan, I.; Obiri, N. 2003: IL-13 receptor specific chimeric proteins and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1267(2)

Daines, M.O.; Basu, S.; Hershey, G.K.K.urana 2004: IL-13 signaling in cells stably expressing FLAG-human IL-13R alpha 2. Journal of Allergy and Clinical Immunology 113(2 Suppl): S324

Singer, M.; Vargaftig, B.B. 2001: IL-13, leukotrienes, and chemokines orchestrate mucipare metaplasia in allergic mouse lung. Inflammation Research 50(Suppl 3): S181

Thompson, C.; Thivierge, M.; Stankova, J.; Rola Pleszczynski, M. 2002: IL-13- and IL-4-induced expression of the leukotriene CysLT1 receptor is abrogated by IFNgamma in human monocytes. Journal of Interferon and Cytokine Research 22(Suppl 1): S-137-S-138

Kaviratne, M.; Hesse, M.; Leusink, M.D.; Roberts, A.B.; Wakefield, L.M.; Davies, S.J.; Mckerrow, J.H.; Cheever, A.W.; Letterio, J.J.; Wynn, T.A. 2003: IL-13-dependent inflammation and tissue fibrosis develop through a MMP-9-, SMAD3-, and TGF-beta-independent mechanism. American Journal of Tropical Medicine and Hygiene 69(3 Suppl): 371-372

Tekkanat, K.K.; Massaab, H.; Cho, D.; Lai, J.; Lukacs, N.W. 2000: IL-13-induced airway hyperreactivity and mucous production during respiratory syncytial virus infection. FASEB Journal 14(6): A1086

Gomperts, B.N.; Flaherty, S.; Hackett, B.P. 2003: IL-13/STAT-6 regulation of foxj1 and loss of cilia in the pulmonary epithelium. Pediatric Research 53(4 Part 2): 569A

Elnekave, E.; Mentink Kane, M.M.; Cheever, A.W.; Wynn, T.A. 2004: IL-13R alpha 2 plays a key regulatory role in the sensitization phase of type-2 immune responses. FASEB Journal 18(4-5): Abstract 336

Rahaman, S.O.; Sharma, P.; Harbor, P.C.; Aman, M.J.; Vogelbaum, M.A.; Haque, S.J. 2001: IL-13Ra2 is a negative regulator of both IL-4- and IL-13-dependent signal transduction. Journal of Interferon and Cytokine Research 24(Suppl 1): S 85

Shinozaki, M.; Salant, D.J.; Rubin/Kelley, V. 2001: IL-15 A protective cytokine in nephrotoxic serum nephritis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 640A

Kozik, M.; Finney, M.; Kadereit, S.; Haynesworth, S.; Koc, O.; Fu, P.; Welniak, L.; Murphy, W.; Laughlin, M.J. 2002: IL-15 Augments CD3+ and CD56+ Lymphocytes and Early NOD/SCID Engraftment of UCB Expanded over Mensenchymal Stem Cells. Blood 100(11): Abstract No. 2058

Manna, P.P. 2003: IL-15 activated human peripheral blood dendritic cell kills allogeneic and xenogeneic endothelial cells via apoptosis. Xenotransplantation 10(5): 511

Tamang, D.L.; Alves, B.; Redelman, D.; Hudig, D. 2004: IL-15 activates T cell cytotoxic potential and induces granzyme B in the absence antigen-specific stimulation and prior to IL-15 dependent proliferation. FASEB Journal 18(4-5): Abstract 330

Wang, H.C.; Dann, S.M.; Robinson, P.; Lewis, D.; Caillant Zucman, S.; Actor, J.K.; White, A.C. 2004: IL-15 activates human NK cells to clear Cryptosporidium parvum infection by upregulating NKG2D. FASEB Journal 18(4-5): Abstract 327

Zhi, W.; Li, Y.; Weng, N. 2004: IL-15 activates telomerase and preserves telomere length in long term cultured memory CD8+ T cells. FASEB Journal 18(4-5): Abstract 553

Salvati, V.M.; Bajaj Elliott, M.; Mazzarella, G.; Borrelli, M.; Riccio, F.; Staiano, A.; Auricchio, S.; Troncone, R. 2000: IL-15 and IL-18 mRNA expression is not upregulated in untreated nor in treated celiac mucosa in vitro cultured with gliadin. JPGN 31(Suppl 3): S24

Koenen, H.J.P.M.; Fasse, E.; Joosten, I. 2003: IL-15 and cognate allogeneic stimulation successfully expand de novo induced human donorspecific regulatory CD4+ T-cells that only show suppression upon allospecific activation. Genes and Immunity 4(Suppl 1): S12

Umemura, M.; Nishimura, H.; Mizuno, S.; Sugawara, I.; Yoshikai, Y. 2002: IL-15 as an immune adjuvant to increase the efficacy of BCG vaccination. Tuberculosis 82(2-3): 129

Saikh, K.U.; Khan, A.S.; Ulrich, R.G. 2000: IL-15 directly induces maturation of CD14+ monocytes to dendritic cells. FASEB Journal 14(6): A1050

Ziolkowska, M.; Koc, A.; Luszczykiewicz, G.; Maslinski, W. 2000: IL-15 enhances thrombin-induced production of IL-8 and TNF-alpha in whole blood culture from healthy individuals. Immunology Letters 73(2-3): 201

Ngo, N.; Choi, S.S.; Nguyen, Q.H.; Roberts, R.L.; Stiehm, E.R. 2000: IL-15 expands neonatal NK cell populations in long-term culture. Journal of Investigative Medicine 48(1): 19A

Santos, A.; Moro, A.; Perea, S.E. 1999: IL-15 expression is induced by IFNalpha in a small cell lung cancer cell line. Cytokine 11(11): 965

Dubois, S.; Waldmann, T.; Tagaya, Y. 2002: IL-15 in cellular communication. Journal of Interferon and Cytokine Research 22(Suppl 1): S-75

Mohamadzadeh, M.; Banchereau, J. 2000: IL-15 is a Langerhans cell differentiation factor. Immunology 101(Suppl 1): 43

Berenzon, D.; Steers, N.; Schwenk, R.; Krzych, U. 2004: IL-15 is directly involved in the maintenance of central not effector memory CD8+ T cells induced by attenuated P berghei sporozoites. FASEB Journal 18(4-5): Abstract 330

Kuczynski, S.; Dworacka, M.; Winiarska, H.; Abramczyk, M.; Wierusz Wysocka, B.; Szczawinska, K. 2003: IL-15 is elevated in sera of patients with diabetes mellitus Type 1. Diabetes and Metabolism 29(Hors serie 2): 4S90

Neely, G.G.; Mody, C.H. 2000: IL-15 is rapidly mobilized from preformed stores to be expressed on the surface of LPS-stimulated monocytes. FASEB Journal 14(6): A1125

Boyer, M.W.; Jurickova, I.; Zhang, K.; Gross, T.G. 2003: IL-15 is required for GVL responses to pediatric ALL/AML blasts. Pediatric Research 53(4 Part 2): 273A

Villinger, F.; Miller, R.; Mori, K.; Mayne, A.E.; Bostik, P.; Sundstrom, J.B.; Sugimoto, C.; Ansari, A.A. 2004: IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 22(25-26): 3510-3521

Praditpornsilpa, K.; Wang, W.; Chan, L. 2001: IL-15 is upregulated by allorecognition in monocyte of human lymphocytes culture. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 865A

Azimi, N.; Mariner, J.; Jacobson, S.; Waldmann, T.A. 2001: IL-15 plays an important role in the pathogenesis of HAM/TSP through activation of the T cells and persistence of antigen specific CD8 cells. AIDS Research and Human Retroviruses 17(Suppl 1): S 27

Lu, J.; Omiya, R.; Kobayashi, H.; Giuntoli, R.L.II.K.nnedy, R.; Celis, E. 2002: IL-15 promotes antigen-independent in vitro expansion and long-term survival of effector CTL. Proceedings of the American Association for Cancer Research Annual Meeting 43: 449

Zissel, G.; Baeumer, I.; Schlaak, M.; Mueller Quernheim, J. 1999: IL-15 release in interstitial lung disease. FASEB Journal 13(4 Part 1): A171

Hiroi, T.; Yanagita, M.; Ohta, N.; Sakaue, G.; Kiyono, H. 1999: IL-15 selectively influences the development of the common mucosal immune system-independent IgA-producing B-1 cells in mucosa-associated tissues. Immunology Letters 69(1): 80-81

Bulanova, E.; Budagian, V.; Orinska, Z.; Bulfone Paus, S. 2002: IL-15 signaling mechanisms in mast cells. Journal of Interferon and Cytokine Research 22(Suppl 1): S-91

Tatari, Z.; Gress, R.; Hakim, F.T. 2000: IL-15 supports the differentiation and expansion of human atypical CD28-CD57+ CD8 subpopulations. FASEB Journal 14(6): A987

Veerapanane, D.; Hamanaka, S.; Nozawa, I. 1999: IL-15 triplex oligonucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1219(4): 3396

Milano, S.; D'agostino, P.; Di Bella, G.; Barbera, C.; La Rosa, M.; Ferlazzo, V.; Caruso, R.; Vitale, G.; Gambino, G.; Mansueto, S.; Cillari, E. 1999: IL-15, a regulator of Th1-type antigen-driven immune response in visceral leishmaniasis. Immunology 98(Suppl 1): 31

Baan, C.C.; Balk, A.H.M.M.; van der Plas, A.J.; van Gelder, T.; Vantrimpont, P.J.M.J.; Maat, L.P.W.M.; Weimar, W. 2002: IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipients. Transplantation Proceedings 34(8): 3243-3245

Center, D.M.; Cruikshank, W.W.; Kornfeld, H. 2004: IL-16 antagonist peptides and DNA encoding the peptides. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)

Center, D.M.; Cruikshank, W.W.; Kornfeld, H. 2004: IL-16 antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1281(3)

Zissel, G.; Ziegenhagen, M.W.; Schlaak, V.; Mueller Quernheim, J. 2000: IL-16 exhibits anti-inflammatory capabilities in interstitial lung diseases. Immunology Letters 73(2-3): 202

Hira, K.; Mitsuishi, K.; Sekiguchi, I.; Ogawa, H. 2004: IL-16 in patients with atopic dermatitis; a possible serological marker of disease activity. Journal of Dermatological Science 34(2): 134

Mathy, N.L.; Kurth, R. 1999: IL-16 induces the production of proinflammatory cytokines. Cytokine 11(11): 955

Parada, N.A.; Fenton, M.; Rodriguez, W.; Danis, H.; Kornfeld, H.; Cruikshank, W.; Center, D.M. 1999: IL-16 inhibits transcription factor binding and IL-2 production in activated T cells. FASEB Journal 13(4 Part 1): A314

Little, F.F.; Kim, S.; Kornfeld, H.; Center, D.; Cruikshank, W. 2002: IL-16 is an immunomodulator in allergic airway inflammation. FASEB Journal 16(4): A675

Ye, G.; Broussard, R.F.; Crowe, S.E.; Reyes, V.E. 1999: IL-16 is produced by gastric epithelial cells and increased in the mucosa during infection with H pylori. Gastroenterology 116(4 Part 2): A849

Seegert, D.; Rosenstiel, P.; Pfahler, H.; Folsch, U.R.; Schreiber, S. 1999: IL-16 levels are increased in patients with Crohns disease and ulcerative colitis. Gastroenterology 116(4 Part 2): A816-A817

Zissel, G.; Pechkovsky, D.V.; Ziegenhagen, M.W.; Einhaus, M.; Taube, C.; Magnussen, H.; Schlaak, M.; Mueller Quernheim, J. 2000: IL-16 mRNA expression but not protein release of human alveolar epithelial cells type II is modulated by TNF-alpha and IFN-gamma. Immunobiology 203(1-2): 151

Mashikian, M.V.; Cruikshank, W.; Brazer, W.; Ryan, T.; Center, D. 1999: IL-16, through interaction with CD4, inhibits CCR5 and CXCR4 but not CCR3 signaling. FASEB Journal 13(4 Part 1): A317

Seegert, D.; Stefan, S. 2000: IL-16-induced activation of the JAK-STAT pathway. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1108-AGA A1109

Rahangdale, S.; Lynch, E.; Heijens, C.; Yamasaki, H.; Ryan, T.; Cruikshank, W. 2004: IL-16/CD4 Mediated Desensitization of CXCR3 Requires the Presence of CCR5. FASEB Journal 18(4-5): Abstract 337

Cruikshank, W.; Jenkins, A.; Ledwich, L.; Vallen, M.; Brazer, W.; Center, D. 1999: IL-16CD4 activation of T cells desensitizes to SDF-1/CXCR4 chemotaxis. Cytokine 11(11): 943

Lubberts, E.; Oppers, B.; Joosten, L.A.B.; Saxne, T.; Van Den Bersselaar, L.; Van Den Berg, W.B. 2001: IL-17 blockade suppressed joint destruction in murine collagen-induced arthritis. Inflammation Research 50(Suppl 3): S175

Ye, P.; Garvey, P.B.; Huang, W.; Good, D.E.; Zhang, Z.; Schwarzenberger, P.; Summer, W.R.; Shellito, J.E.; Nelson, S.; Kolls, J.K. 1999: IL-17 increases lung immunity and help lung host defense against K Pneumoniae infection. Journal of Investigative Medicine 47(2): 135A

Vives, V.; Sautes Fridman, C.; Warnier, G.; Fossiez, F.; Fridman, W.H.; Tartour, E. 2000: IL-17 inhibits tumor cell growth via a T cell dependent mechanism. Proceedings of the American Association for Cancer Research Annual Meeting 41: 116

Kinugasa, T.; Macdermott, R.P.; Reinecker, H.C.ristian 1999: IL-17 is a regulator of intestinal epithelial cell barrier function. Gastroenterology 116(4 Part 2): A574-A575

Ganapamo, F.; Dennis, V.A.; Philipp, M.T. 2004: IL-17 is differentially produced by lymph node cells of C3H/HeJ and C57BL/6J mice infected with Borrelia burgdorferi. FASEB Journal 18(4-5): Abstract 330

Huang, W.; Kolls, J.K.; Byrne, P.; Manuel, M.; Oliver, P.; Schwarzenberger, P. 2000: IL-17 mobilizes peripheral blood stem cells with short and long term reconstituting ability in mice. Journal of Investigative Medicine 48(1): 146A

L.R.ssa, V.F.; Schwartzenberger, P.; Miller, A.; Kohls, J.; Scher, C.; Warrier, R.P.; Weimer, R.; Alzobie, A. 2000: IL-17 priming increases the engraftment potential of highly purified CD34+ hematopoietic stem cells on individual mesenchymal/stromal progenitor derived stromal cell colonies. Blood 96(11 Part 2): 150b-151b

Da Matta Guedes, P.M.; Gutierrez, F.R.S.; Maia, F.L.; Milanezi, C.M.; Silva, G.K.; Pavanelli, W.R.; Silva, J.ão.S. 2010: IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. Plos Neglected Tropical Diseases 4(2): E604

Chabaud, M.; Aarwak, T.; Natvig, J.; Miossec, P. 1999: IL-17 producing Th1 cells from RA synovium induce a destructive pattern upon contact with synoviocytes. Arthritis and Rheumatism 42(9 Suppl): S161

Chen, J.; Filvaroff, E.; Fong, S.; Goddard, A.; Godowski, P.; Grimaldi, C.; Gurney, A.; Li, H.; Hillan, K.; Tumas, D.; Vanlookeren, M.; Vandlen, R.; Watanabe, C.; Williams, P.M.; Wood, W.I.; Yansura, D. 2003: IL-17 related mammalian cytokine polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1271(3)

Vicente, A.B.; Mojaat, A.; Fessele, S.; Schlondorff, D.; Nelson, P.J. 2001: IL-17 suppresses TNF-alpha/IFN-gamma induced expression of RANTES/CCL5 in fibroblast cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 643A

Kurowska, M.; Kontny, E.; Chorazy, M.; Rudnicka, W.; Kowalczewski, J.; Zubiaur, M.; Sacho, J.; Maslinski, W. 2000: IL-17 triggers rheumatoid arthritis synoviocytes B to enhance the expression of both cyclooxygenases whose enzymatic activities are effectively blocked in the presence of different NSAIDs. Immunology Letters 73(2-3): 155

Bonneau, O.; Ferreti, S.; Jones, G.D.bois Carol; Trifilieff, A. 2003: IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia. British Journal of Pharmacology 138(Proceedings Suppl): 79P

Kanczler, J.M.; Bodamyali, T.; Millar, T.M.; Jefferiss, C.M.; Blake, D.R.; Stevens, C.R. 2000: IL-17-induced mouse calvarial bone resorption is associated with increased levels of nitric oxide. Nitric Oxide 4(3): 296

Gorman, D.M.; Bazan, J.F.; Kastelein, R.A. 2003: IL-17-like cytokine binding compounds and antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1270(2)

Danilenko, D.M.; Kim, M.R.; Manoukian, R.; Derose, M.; Chang, D.; Nguyen, H.; Elliott, G.; Medlock, E.S. 2002: IL-17E, a novel member of the IL-17 cytokine family, induces marked eosinophilic and granulomatous inflammation in transgenic mice. FASEB Journal 16(5): A1084

Starnes, T.; Robertson, M.; Sledge, G.; Kelich, S.; Nakshatri, H.; Broxmeyer, H.E.; Hromas, R. 2001: IL-17F, a novel cytokine selectively expressed in activated T-cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. Blood 98(11 Part 1): 818a-819a

Starovasnik, Melissa A.; Hymowitz, Sarah G.; Yin, Jianping; De Vos, Abraham M. 2002: IL-17s adopt a cystine knot fold Implications for receptor binding. FASEB Journal 16(4): A523

Goess, C.; Leach, M.; Syed, J.; Pietras, M.; Kim, Y.I.; Ghayur, T.; Presky, D.H.; Wang, L.C.un 2004: IL-18 Increases Severity of Renal Disease in a Murine Model of SLE. FASEB Journal 18(4-5): Abstract 779

Zhou, X.; Barber, H.; Butkus, D.E.; Mcdaniel, L.S.; Mangilog, B.; Mcdaniel, O. 2003: IL-18 and IFN-gamma genotype correlation with allograft function in African-American renal transplant patients. Human Immunology 64(Suppl 1): S11

Sugaya, M.; Nakamura, K.; Tamaki, K. 1999: IL-18 and IL-12 synergistically upregulate IFN01gamma production by murine dendritic epidermal T cells. Journal of Investigative Dermatology 112(4): 579

Matsumoto, K. 2000: IL-18 and IL-12 synergize to stimulate the production of vascular permeability factor by T cells in patients with minimal-change nephrotic syndrome. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 548A

Koizumi, H.; Sato Matsumura, K.; Yu, B.; Ohkawara, A.; Seya, T. 1999: IL-18 and IL-18 receptor expression in human keratinocytes. Journal of Investigative Dermatology 112(4): 622

Byrne, F.R.; Brown, H.L.; Flores, S.; Danilenko, D.; Faggioni, R.; Senaldi, G. 2001: IL-18 and IL-18BP have differing effects on the induction or recovery phase of the DSS model of colitis. Journal of Leukocyte Biology Suppl: 83

Kim, Y.I.; Cho, D.H.; Kang, J.S.; Ham, E.S.; Lee, K.M.; Kang, C.J.; Kim, S.H.; Hur, D.Y.; Kim, D.J.; Yun, S.Y.; Chang, K.Y.; Song, H.K.; Choi, I.P.; Kim, Y.B.; Lee, W.J. 2001: IL-18 and IL-2 synergistically augment the cytotoxicity of NK cells against B16 murine melanoma by an enhancement of granule exocytosis. FASEB Journal 15(4): A360

Berman, S.; Averbukh, Z.; Hershkoviz, R.; Bril, A.; Golan, E.; Weissgarten, J. 2002: IL-18 and IL17, but not IL-12, stimulate proliferation and trigger enhanced apoptosis in cultured mesangial cells following contralateral nephrectomy. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 70-71

Sivakumar, P.V.; Westrich, G.; Viney, J.L. 2000: IL-18 and mouse models of inflammatory bowel disease. FASEB Journal 14(6): A976

Raoul, J.M.; Froom, J.; Peterson, T.C. 2003: IL-18 and the therapeutic effects of pentoxifylline and metabolite-1 in a rat model of inflammatory bowel disease. European Cytokine Network 14(Suppl 3): 61

Peterson, M.R.; Snair, J.; Peltekian, K.M.; Peterson, T.C. 2003: IL-18 as an indicator of fibrosis in HCV patients. European Cytokine Network 14(Suppl 3): 60

Oliveira, J.G.G.; Xavier, P.; Sampaio, S.; Mendes, A.; Pestana, M. 2001: IL-18 associates with acute rejection post-renal transplantation. Nephrology Dialysis Transplantation 16(6): A199

Lonnemann, G.; Novick, D.; Rubinstein, M.; Schwartzburd, B.; Swissa, D.; Belzer, I.; Dinarello, C.A. 2000: IL-18 binding protein in chronic renal disease. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 69A

Faggioni, R.; Cattley, R.C.; Guo, J.; Flores, S.; Brown, H.; Scully, S.; Chen, C.; Yamane, H.; Meng, T.; Martin, F.; Hu, S.; Boone, T.; Senaldi, G. 2001: IL-18 binding protein protects against LPS-induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. Journal of Leukocyte Biology Suppl: 26

Reznikov, L.L.; Kim, S.H.; Westcott, J.Y.; Frishman, J.; Fantuzzi, G.; Novick, D.; Rubinstein, M.; Dinarello, C.A. 1999: IL-18 binding protein upregulates spontaneous and IL-1-induced PGE2 production in human peripheral blood mononuclear cells. Cytokine 11(11): 949

Podolin, P.L.; Davis, T.G.; Bolognese, B.J. 2000: IL-18 exacerbates experimental autoimmune encephalomyelitis in the SJL/J mouse, and suppresses EAE in the C57BL/6 mouse. FASEB Journal 14(6): A1211

Suri, M.; Wu, J.; Cairo, S.; Van, D.V.n, C.; Baxi, L.; Cairo, M. 2002: IL-18 gene expression and protein production are significantly decreased in activated cord blood vs adult peripheral blood mononuclear cells. Journal of Investigative Medicine 50(2): 184A

Blom, J.M.C.; Conti, B.; Tascedda, F.; Barden, N.; Ferraguti, C.; Brunello, N. 1999: IL-18 gene expression in transgenic mice with impaired glucocorticoid receptor function. Society for Neuroscience Abstracts 25(1-2): 700

Mcdaniel, O.D.; Yamout, S.; Aru, G.; Moore, C.K. 2003: IL-18 gene polymorphism and expression correlates with coronary vasculopathy following transplantation. Human Immunology 64(Suppl 1): S10

Walter, D.M.; Wong, C.; Dekruyff, R.H.; Berry, G.; Levy, S.; Umetsu, D.T. 2000: IL-18 gene transfer by adenovirus into the lungs prevents and reverses allergen-induced airway hyperreactivity. FASEB Journal 14(6): A1066

Nakanishi, K.; Tsutsui, H.; Okamura, H.; Yoshimoto, T. 1999: IL-18 has potential to stimulate IL-4 production by basophils but with IL-12 only exhibits its anti-allergic action in vivo. Cytokine 11(11): 950

Ohta, Y.; Hamada, Y.; Amou, Y.; Nagase, A.; Katsuoka, K. 2000: IL-18 in psoriatic scales. Journal of Dermatological Science 23(3): 213

Mizutani, H.; Yamanaka, K.; Konishi, H.; Murakami, T.; Nakanishi, K. 2001: IL-18 induces IgE production in caspase-1 transgenic mice and wild type mice Dependence on IL-4 and STAT6. Journal of Investigative Dermatology 117(2): 458

Shoji, T.; Nakanishi, K.; Nakanishi, I.; Okamura, H.; Imai, E.; Tsubakihara, Y. 2001: IL-18 induces IgE production in minimal change disease. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 125A

Yoshimoto, T.; Tsutsui, H.; Okamura, H.; Mizutani, H.; Noben Trauth, N.; Paul, W.E.; Nakanishi, K. 2001: IL-18 induces IgE production in wild type and caspase-1 transgenic mice Dependence on CD4+ T cells, IL-4 and Stat6. FASEB Journal 15(4): A347

Soos, J.M.; Polsky, R.M.; Gore, E.R.; Keegan, S.P.; Speal, B.A.; Jonak, Z.L.; Bugelski, P.J.; Herzyk, D.J. 2001: IL-18 induction of dendritic cell and monocyte derived neopterin in human and non-human primates. FASEB Journal 15(5): A1205

Soos, J.M.; Polsky, R.M.; Gore, E.R.; Jonak, Z.L.; Bugelski, P.J.; Herzyk, D.J. 2000: IL-18 induction of neopterin Identification of a surrogate biomarker for IL-18 activity in non-human primates. Inflammation Research 49(Suppl 2): S102

Sivakumar, P.V.; Westrich, G.M.; Kanaly, S.; Sims, J.; Derry, J.; Viney, J.L. 2001: IL-18 is a primary mediator of inflammation associated with DSS-induced colitis Blocking IL-18 prevents intestinal damage. Gastroenterology 120(5 Suppl 1): A692-A693

Hewins, P.; Morgan, M.; Holden, N.; Savage, C.O.S.; Harper, L. 2003: IL-18 is important in driving neutrophil responses in ANCA-associated vasculitis. Kidney and Blood Pressure Research 26(4): 264

Hoshino, T.; Wiltrout, R.H.; Young, H.A. 1999: IL-18 is much more than an inducer of interferon-gamma A role for IL-18 in IL-13 production. FASEB Journal 13(5 Part 2): A651

Moore, M.B.; Fullenkamp, C.A.; Lutz, C.T. 2000: IL-18 is necessary for squamous cell carcinoma cells to stimulate NK cell IFN-gamma release. FASEB Journal 14(6): A1008

Kanai, T.; Okazawa, A.; Nakamura, K.; Kurimoto, M.; Hibi, T.; Sakae, M.; Totsuka, T.; Ishikura, T.; Nomura, T.; Ishii, K.; Yamazaki, M.; Watanabe, M. 2001: IL-18 is produced by human intestinal cells and enhances intraepithelial lymphocyte proliferation synergistically with IL-2, IL-7, and IL-15. Gastroenterology 120(5 Suppl 1): A 316

Ho, L.P.; Davis, M.; Denison, A.; Wood, F.T.; Greening, A.P. 2000: IL-18 levels are markedly reduced in broncho-alveolar lavage from asthmatics compared to sarcoids and normal subjects. Thorax 55(Suppl 3): A58

Tomita, T.; Hida, N.; Dixon, M.F.; Axon, A.T.R.; Hyatt, M.; Crabtree, J.E. 1999: IL-18 mRNA expression is elevated in Helicobacter pylori infected gastric mucosa. Gastroenterology 116(4 Part 2): A693

Hong, T.P.; Andersen, N.A.; Karlsen, A.E.; Puren, A.J.; Fantuzzi, G.; Dinarello, C.A.; Mandrup Poulsen, T. 1999: IL-18 mRNA, but not IL-18 receptor mRNA, is constitutively expressed in islet beta-cells. Diabetologia 42(Suppl 1): A155

Jonak, Z.L.; Ho, Y.S.; Trulli, S.; Mccabe, F.L.; Maier, C.; Kirkpatrick, R.; Elefante, L.; Chen, Y.J.; Herzyk, D.; Johanson, K.; Lotze, M.T.; Johnson, R.K. 2000: IL-18 mediates antitumor effects in advanced murine tumor models. Journal of Immunotherapy 23(5): 598

Kim, S.H.; Azam, T.; Yoon, D.Y.; Novick, D.; Rubinstein, M.; Senaldi, G.; Dinarel, C.A. 2001: IL-18 mutants with enhanced biological activities and decreased IL-18BP neutralization. Journal of Leukocyte Biology Suppl: 55

Yunger, T.M.; Mehta, V.; Hart, J.; Wewers, M.D. 2000: IL-18 production and processing in normal human alveolar macrophages. Journal of Investigative Medicine 48(5): 257A

Vankayalapati, R.; Wizel, B.; Weis, S.; Samten, B.; Girard, W.; Barnes, P. 2000: IL-18 production in human tuberculosis. FASEB Journal 14(6): A1061

Shinoda, M.; Wakabayashi, G.; Shimazu, M.; Hoshino, K.; Tanabe, M.; Morikawa, Y.; Kitajima, M. 2001: IL-18 production in patients with fulminant hepatic failure. Hepatology 34(4 Pt 2): 283A

Cho, D.H.; Park, H.J.; Kim, Y.I.; Kang, J.S.; Ham, E.S.; Kim, S.H.; Hur, D.Y.; Kim, D.J.; Yun, S.Y.; Lee, K.M.; Kang, C.J.; Chang, K.Y.; Kim, Y.B.; Lee, W.J. 2001: IL-18 production is enhanced in malignant human skin tumors. FASEB Journal 15(5): A1205

Nutku, E.; Aris, F.; Soussi Gounni, A.; Hamid, Q. 2001: IL-18 receptor expression by human eosinophils Regulation of eosinophil associated IL-18R expression. Journal of Allergy and Clinical Immunology 107(2): S35

Sims, J.E.; Born, T.L. 2003: IL-18 receptor fusion proteins. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)

Nomura, A.; Takada, H.; Jin, C.; Ohga, S.; Hara, T. 2000: IL-18 response of cord blood T and NK cells. FASEB Journal 14(6): A1180

Wild, J.S.; Choudhury, B.K.; Alam, R.; Sur, S. 2001: IL-18 stimulates Th2 differentiation in an IL-4 independent manner. Journal of Allergy and Clinical Immunology 107(2): S60

Garcia, G.E.; Xia, Y.; Ku, G.; Johnson, R.J.; Wilson, C.B.; Feng, L. 2003: IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis. Kidney International 64(1): 160-169

Hodge, D.L.; Schill, W.B.; Reynolds, D.A.; Subleski, J.J.; Young, H.A. 2002: IL-18 upregulation of TRAF1 expression is coincident with decreased apoptosis and TNF activation of NFB in primary NK cells. Journal of Interferon and Cytokine Research 22(Suppl 1): S-104

Peterson, T.C.; Jones, J.; Tanton, R.T. 2003: IL-18, FSI and P-III-P in inflammatory bowel disease. European Cytokine Network 14(Suppl 3): 60

O'connor, J.J.; Curran, B.P. 2000: IL-18, the novel pro-inflammatory cytokine, inhibits long-term potentiation in the rat dentate gyrus in vitro. European Journal of Neuroscience 12(Suppl 11): 360

Johnson, R.K. 2003: IL-18/IGIF chemotherapeutic compositions. Official Gazette of the United States Patent and Trademark Office Patents 1271(4)

Rega, F.; Vanaudenaerde, B.; Wuyts, W.; Jannis, N.; Verleden, G.; Lerut, T.; Van Raemdonck, D. 2003: IL-1B in broncho-alveolar lavage is a non-invasive predictor of the viability of the pulmonary graft from the non-heart-beating donor. Journal of Heart and Lung Transplantation 22(1S): S213

Guerra, J.B.; Santos, A.; Magalhaes, P.P.; Simpson, A.J.G.; Camargo, A.A.; Rocha, G.A.; Rocha, A.M.C.; Queiroz, D.M.M. 2002: IL-1B polymorphism and p53 gene mutation in H pylori associated gastric carcinoma. Gut 51(Suppl 2): A54

Zur Hausen, A.; Crusius, J.B.A.; Murillo, L.S.; Alizadeh, B.Z.; Morré, S.A.; Meijer, C.J.L.M.; van den Brule, A.J.C.; Peña, A.S. 2003: IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma. International Journal of Cancer 107(5): 866-867

Zur Hausen, A.; Crusius, J.B.A.; Alizadeh, B.Z.; Murillo, L.S.; Meijer, C.J.L.M.; Van Den Brule, A.J.C.; Pena, A.S. 2003: IL-1B promoter polymorphism in Dutch patients with EBV-carrying and EBV negative gastric carcinoma. Pathology Research and Practice 199(4): 251

Towne, J.E.; Garka, K.E.; Renshaw, B.R.; Sims, J.E. 2003: IL-1F6, IL-1F8 and IL-1F9 signal through IL-1Rrp2 to activate NFkappaB and MAP kinases. European Cytokine Network 14(Suppl 3): 89

Bufler, P.; Kim, S.H.; Kumar, S.; Dinarello, C.A. 2001: IL-1H4 , a novel member of the interleukin-1 gene family, is regulated by LPS and induces IL-8 but not IFNgamma. Journal of Leukocyte Biology Suppl: 35-36

Ray, K.K.; Francis, S.E.; Crossman, D.C. 2002: IL-1RN gene polymorphism predicts a proinflammatory endothelial cell phenotype in HUVEC-implications for atherogenesis and plaque rupture. European Heart Journal 23(Abstract Suppl): 594

Ray, K.K.; Francis, S.E.; Crossman, D.C. 2003: IL-1RN gene polymorphism predicts clinical events up to 1 year after a non-ST-elevation acute coronary syndrome An association independent of troponin T and C-reactive protein. European Heart Journal 24(Abstract Suppl): 70

Jeremy, A.H.T.; Holland, D.B.; Seukeran, D.C.; Cunliffe, W.J. 2000: IL-1alpha activity in inflammatory acne. British Journal of Dermatology 142(3): 619

Nyberg, P.; Wikman, A.L.; Nennesmo, I.; Lundberg, I. 1999: IL-1alpha and MHC class I Possible mediators of the chronic muscle weakness and fatigue in patients with polymyositis and dermatomyositis. Arthritis and Rheumatism 42(9 Suppl): S158

Paola, T.; Federica, M.; Marco, C.; Adriano, P.; Claudio, F. 2000: IL-1alpha and TNF-alpha induce urokinase plasminogen activator mRNA in pemphigus vulgaris. Journal of Investigative Dermatology 115(3): 579

Singer, C.F.; Kronsteiner, N.; Marton, E.; Walter, I.; Kubista, M.; Czerwenka, K.; Schreiber, M.; Tschugguel, W.; Wieser, F.; Kubista, E. 2002: IL-1alpha gene expression in human endometrial cancer is independent of ovarian steroid receptor expression. European Journal of Cancer 38(Suppl 6): S76-S77

Tahara, S.M.; Johnson, D.L. 2003: IL-1alpha mRNA binding proteins activated by nitric oxide in mouse RAW2647 cells. FASEB Journal 17(4-5): Abstract 128

Dayan, S.; Gallagher, G.; Kupper, T. 2001: IL-1alpha overexpression accelerates head and neck SCC in mice. Journal of Investigative Dermatology 117(2): 472

Pratt, A.; Morgan, A.W.; Griffiths, B.; Wilson, K.E.; Ponchel, F.; Markham, A.F.; Boylston, A.W.; Situnayake, R.D.; Emery, P.; Isaacs, J.D. 1999: IL-1alpha polymorphism and rheumatoid arthritis. Immunology 98(Suppl 1): 119

Von Stebut, E.; Belkaid, Y.; Nguyen, B.; Sacks, D.L.; Udey, M.C. 2001: IL-1alpha promotes Th1 development in experimental cutaneous leishmaniasis in BALB/c mice and facilitates parasite killing in vivo. Archives of Dermatological Research 293(1-2): 37

Udey, M.; Ehrchen, J.; Belkaid, Y.; Lopez Kostka, S.; Moelle, K.; Knop, J.; Sunderkoetter, C.; Von Stebut, E. 2003: IL-1alpha promotes Th1-differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. Journal of Investigative Dermatology 121(5): 1234

Murphy, J.E.; Dayan, S.; Kupper, T.S. 2000: IL-1alpha protects against carcinoma generation in skin by blocking papilloma formation and exerts its effects independent of the acquired immune system. Journal of Investigative Dermatology 114(4): 765

Santos, P.; Santos, P.; Balseiro, S.; Ballesteros, R.; Mareco, R.; Vale Pereira, S.; Paiva, A.; Martinho, A.; Goncalves, I.; Perdigoto, R.; Regateiro, F. 2003: IL-1alpha, IL-1beta, IL-1R, IL-1RA, IL4-RA, IL-12, IFN-gamma, TGF-beta, TNF-alpha, IL-2, IL-4, IL-6 and IL-10 gene polymorphism in rejection and infection after liver transplantation. Genes and Immunity 4(Suppl 1): S55

Gurjar, M.V.; Sharma, R.V.; Bhalla, R.C. 2000: IL-1b-stimulated MMP-9 induction is dependent on MAP kinase activation and is inhibited by NO in VSM cells. FASEB Journal 14(4): A707

Whiteley, S.J.; Klassen, H.; Coffey, P.J.; Young, M.J. 2001: IL-1beta ameliorates visual function deterioration and photoreceptor degeneration in the RCS rat. IOVS Investigative Ophthalmology and Visual Science 42(4): S631

Weinreb, R.N.; Angert, M.; Lindsey, J.D. 2000: IL-1beta and EGF can influence latanoprost-mediated increases matrix metalloproteinase-1 mRNA in human ciliary muscle cultures. IOVS Investigative Ophthalmology and Visual Science 41(4): S573

E.O., E.M.; You, W.C.; Chow, W.H.; Fraumeni, J.F.Jr.; Rabkin, C.S. 2001: IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China. Gastroenterology 120(5 Suppl 1): A 743

Campagnuolo, G.; Bolon, B.; Zhu, L.; Duryea, D.; Feige, U.; Zack, D. 2003: IL-1beta and TNF-alpha produce divergent acute inflammatory and skeletal lesions in the knees of Lewis rats. Chiorazzi, Nicholas , Reprint Author, Lahita, Robert G, Capra, J Donald, Ferrarini, Manlio, Zabriskie, John B Immune mechanisms and disease: 295-298

Sandell, L.J.; Fukui, N.; Zhu, Y. 2003: IL-1beta and TNF-alpha stimulate repair processes in human osteoarthritic cartilage through induction of BMP-2. FASEB Journal 17(4-5): Abstract 214

Clarke, D.J.; Ahmad, I.; Branton, R.L. 2000: IL-1beta and TNF-alpha; their effect on embryonic dopaminergic neurons in vitro and release following neural transplantation. European Journal of Neuroscience 12(Suppl 11): 292

Ferrer, F.A.; Miller, L.J.; Mckenna, P.H.; Kruetzer, D.L. 1999: IL-1beta and TNFalpha regulation of interleukin-8 in human neuroblastoma tumor cells in-vitro. Pediatrics 104(3 Part 3): 817

Nakai, S.; Kaneta, M.; Kikumoto, Y.; Hong, Y.M.; Kawai, K.; Takegata, S.; Ishii, K.; Yanagihara, Y.; Hirai, Y. 2000: IL-1beta and derivatives thereof and drugs. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)

Hood, K.C. 2003: IL-1beta attenuates the preventive effect of beta-agonists in vivo and in vitro. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S142

Polizzi, S.M.; Long, C.S.; Brown, R.D.le 2001: IL-1beta but not IFN-gamma stimulates TGFbeta isoform switching in cardiac fibroblasts. FASEB Journal 15(5): A1047

Sahni, A.; Guo, M.; Sahni, S.K.; Francis, C.W. 2003: IL-1beta but not IL-1a binds fibrinogen and fibrin and demonstrates enhanced activity in the bound form. Blood 102(11): 782a

Ohama, T.; Hori, M.; Sato, K.; Karaki, H.; Ozaki, H. 2004: IL-1beta conduct gastrointestinal motility disorders by decrease in CPI-17 expression in ileal smooth muscle. Journal of Pharmacological Sciences 94(Suppl 1): 143P

Reddy, S.; Young, M. 2002: IL-1beta expression in islet cells of the NOD mouse and its spatial relationship to beta cells and inducible nitric oxide synthase. Annals of the new York Academy of Sciences 958: 190-193

Eibl, G.; Reber, H.A.; Okada, Y.; Duffy, J.P.; Hines, O.J. 2003: IL-1beta increases COX-2 expression in human pancreatic cancer cells through multiple intracellular pathways. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1012-1013

Tribe, R.M.; Moriarty, P.; Dancy, A.; Poston, L. 2000: IL-1beta increases capacitative calcium entry in primary cultured pregnant human myometrial cells. Journal of Obstetrics and Gynaecology (Abingdon) 20(Suppl 1): S58

Kiriu, M.; Kaneki, H.; Ide, H. 2001: IL-1beta increases osteoclast differentiation in the co-cultures of bone marrow cells and calvarial osteoblasts from adult rats. Journal of Bone and Mineral Research 16(Suppl 1): S503

Wong, V.H.; Fewell, J.E. 2002: IL-1beta induced fever does not alter the ability of 5 to 6 day-old rat pups to autoresuscitate from hypoxic induced apnea. FASEB Journal 16(5): A815

Maliner, S.; Bowden, G.T. 2000: IL-1beta induced matrilysin expression is mediated by transcription factor NFkappaB through an indirect mechanism. Proceedings of the American Association for Cancer Research Annual Meeting 41: 830

Barragan, E.I.; Avila, S.A.; Chafrat, V.; Cerdeira, J. 2001: IL-1beta induces FGF production in the embryonic chick retina. Developmental Biology 235(1): 226

Ryan, R.E. 2002: IL-1beta induces an anoikis-like cell death in OVCAR-3 ovarian carcinoma cells Comparison to IL-1beta mediated detachment of viable A375S2 melanoma cells from monolayer cultures. Proceedings of the American Association for Cancer Research Annual Meeting 43: 886

Han, R.; Smith, T.J. 2003: IL-1beta induces tissue inhibitor of metalloprotenase type 1 production in orbital fibroblasts. FASEB Journal 17(4-5): Abstract 160

Sternesjo, J.; Karlsen, A.E.; Sandler, S. 2000: IL-1beta induces transcription of proteasome subunits. Diabetologia 43(Suppl 1): A123

Li, Y.; Taneja, R.; Parodo, J.; Rotstein, O.D.; Marshall, J.C. 1999: IL-1beta inhibits neutrophil apoptosis through differential activation of survival genes. FASEB Journal 13(5 Part 2): A975

Staats, H.F.; Sparks, N.; Casey, L.; Nabors, G.; Dondero, R.S. 1999: IL-1beta is an effective adjuvant for nasal vaccines. Cytokine 11(11): 961

Ross, F.M.; Allan, S.M.; Bristow, D.; Rothwell, N.J.; Verkhratsky, A. 2002: IL-1beta is involved in temperature-associated changes in synaptic plasticity in mouse hippocampal slices. Journal of Physiology (Cambridge) 543P: 19P

Zimmerman, T.L.; Ghose, R.; Thevananther, S.; Karpen, S.J. 2003: IL-1beta mediated modification and nucleo-cytoplasmic translocation of RXRalpha involves JNK. Hepatology 38(4 Suppl 1): 391A

Gilmore, G.A.; Logan, C.; Mcallister, K.; Gilmore, W.S.; Wallace, J.M.W. 2002: IL-1beta production is higher in endotoxin stimulated monocytes from apparently healthy young smokers. Journal of Interferon and Cytokine Research 22(Suppl 1): S-138-S-139

Tsujita, E.; Shimada, M.; Maehara, S.I.; Tanaka, S.; Shirabe, K.; Maehara, Y. 2003: IL-1beta promotes peritoneal-disseminating metastasis of human cholangiocarcinoma cell line, HUCCT-1. Proceedings of the American Association for Cancer Research Annual Meeting 44: 58

Hansen, M.K.; Nguyen, K.T.; Fleshner, M.; Goehler, L.E.; Gaykema, R.P.A.; Maier, S.F.; Watkins, L.R. 1999: IL-1beta protein and IL-1beta, IL-1 receptor type I, and IL-1 receptor accessory protein mRNA are present in normal brain and are modulated by LPS. Society for Neuroscience Abstracts 25(1-2): 1446

Andre, R.; Pinteaux, E.; Moggs, J.; Parker, L.C.; Kimber, I.; Rothwell, N.J. 2003: IL-1beta signalling in the brain in the absence of IL-1R1. European Cytokine Network 14(Suppl 3): 87

Wang, Y.; Li, Xiaomei; Wang, Haiyan 2001: IL-1beta stimulates alpha-smooth muscle actin expression through JNK/p38 signaling pathway in cultured rat mesangial cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 696A

Veluthakal, R.; Amin, R.; Kowluru, A. 2003: IL-1beta treatment is associated with detrimental nuclear changes in insulin secreting RINm5F cells. Diabetes 52(Suppl 1): A357

Jablonska, E.; Marcinczyk, M.; Izycka, A.; Hermanowska Szpakowicz, T.; Jablonski, J. 2002: IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC from patients with Lyme disease. Journal of Interferon and Cytokine Research 22(Suppl 1): S-162

Sabbadini, M.; Barisani, D.; Conforti, E.; Miserocchi, G.; Meneveri, R. 2002: IL-1beta, IL-6 and TNFalpha mRNA expression in mild pulmonary interstitial edema. FASEB Journal 16(5): A1146

Bovin, L.F.; Fredman, P.; Bendtzen, K.; Buschard, K. 1999: IL-1beta, IL-6 and other cytokines are influenced by sulphatide and its precursor galactosylceramide. Diabetes 48(Suppl 1): A430-A431

Lim, J.H.; Lee, J.; Choi, C.; Park, J.Y.; Kim, J.D.; Kim, S.J.; Choi, I.H. 1999: IL-1beta, TNF-alpha or IFN-gamma regulates the expression of BRG-1 associated factor 155/170 in astrocytoma cell lines and primary astrocytes. FASEB Journal 13(5 Part 2): A653

Lello Santos, F.R.; Moyses, R.M.A.; Jorgetti, V.; Noronha, I.L. 2000: IL-1beta, TNF-alpha, TGF-beta and bFGF expression in bone biopsies from patients with renal osteodystrophy disease. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 555A-556A

Thompson, R.D.; Larbi, K.Y.; Harrison, V.; Duncan, G.S.; Mak, T.W.; Nourshargh, S. 1999: IL-1beta-induced leukocyte responses in cremasteric venules of mice deficient in PECAM-1. FASEB Journal 13(5 Part 2): A670

Nosov, M.A.; Barabamova, S.V.; Golovko, O.I. 1999: IL-1beta-induced production of IL-2 protein in murine brain. Neuroimmunomodulation 6(6): 435

Lukiw, W.J.; Bazan, N.G. 2000: IL-1beta-modulated gene expression in normal human neural progenitor cell lines using high density cDNA arrays. Journal of Neurochemistry 74(Suppl ): S23

Jansen, M.; Lin, P. 2000: IL-1cntdot induced proteoglycan degradation might be regulated by NF-kappaB in bovine articular chondrocytes. Inflammation Research 49(Suppl 2): S91

Sereti, I.; Martinez Wilson, H.; Metcalf, J.A.; Lane, H.C.ifford 2001: IL-2 administration to HIV infected patients leads to expansion of the naive pool of CD4+ T lymphocytes in association with increased expression of the alpha chain but not the beta chain of the IL-2 receptor. FASEB Journal 15(5): A1055

Dooms, H.; Kahn, E.; Knoechel, B.; London, C.A.; Abbas, A.K. 2002: IL-2 and CD28 signals are required for the generation of memory T cells. FASEB Journal 16(4): A341

Curiel, R.E.; Garcia, C.S.; Mwatibo, J.M.; Espinoza Delgado, I. 1999: IL-2 and IFN-gamma differentially regulate B7-2 expression on human monocytes. Proceedings of the American Association for Cancer Research Annual Meeting 40: 76

Kircheis, R.; Kuepcue, Z.; Wallner, G.; Wagner, E. 1999: IL-2 and IFNgamma gene-modified tumor cells for prophylactic and therapeutic vaccination Syngeneic and allogeneic vaccination models in mice. Anticancer Research 19(3A): 2006

Perrella, A.; Conca, P.; Sorrentino, P.; Ragucci, P.; Tarantino, G. 2001: IL-2 and IL-10 serum levels in patients suffering from chronic hepatitis C under IFN therapy. Hepatology 34(4 Pt 2): 517A

Zhou, W.; Aune, T.M. 2002: IL-2 and IL-12 are equivalent Th1/Tc1 differentiation factors in NOD mice. FASEB Journal 16(5): A1061

Cai, S.; Zhen, X.; Wei, H.; Sun, R.; Tian, Z. 2003: IL-2 and IL-15 differently control the development of human NK cell subsets from cord blood mononuclear cells in an in vitro system. FASEB Journal 17(7): C1

Waldmann, T.; Jacobson, S.; Azimi, N. 2001: IL-2 and IL-15 play roles in the pathogenesis and persistence of HTLV-I associated ATL and TSP/HAM Implications for therapy. AIDS Research and Human Retroviruses 17(Suppl 1): S 26

Vamosi, G.; Bodnar, A.; Waldmann, T.A.; Damjanovich, S. 2003: IL-2 and IL-15 receptors sharing lipid rafts are neighbors in similar molecular microenvironments on human T-lymphocytes. European Biophysics Journal 32(3): 311

Kaminski, A.; Demaine, A.; Prentice, A.G. 2001: IL-2 and IL-4 antisense and apoptosis of B-CLL cells. Experimental Hematology 29(8 Suppl 1): 38

Grishina, L.V.; Sennikova, Y.A.; Sennikov, S.V.; Kozlov, V.A. 2002: IL-2 and IL-4 production by PBMC of the people, who were exposed to radiation influence resulted from action at Semipalatinsk nuclear range. Journal of Interferon and Cytokine Research 22(Suppl 1): S-119

Kaminski, A.; Demaine, A.; Prentice, A.G. 2000: IL-2 and IL-4 specific and control antisense oligonucleotides can induce apoptosis of the malignant B-CLL cell. Blood 96(11 Part 2): 276b-277b

Macejova, Z.; Petrasova, D.; Trejbal, D.; Spisak, B.; Wagnerova, H. 1999: IL-2 and PRL responses to TRH IV in control group and women with rheumatoid arthritis and hypotyroidism. Journal of Autoimmunity (Suppl ): 101

Schimpl, A.; Berberich, I.; Kneitz, B.; Krämer, S.; Santner-Nanan, B.; Wagner, S.; Wolf, M.; Hünig, T. 2002: IL-2 and autoimmune disease. Cytokine and Growth Factor Reviews 13(4-5): 369-378

Angevin, E.; Maincent, K.; Hartmann, O.; Leboulaire, C.; Beaussier, P.S.; Zitvogel, L.; Beaujean, F.; Valteau Couanet, D. 2000: IL-2 and/or dendritic cells for NK cell activation in the conditioning of peripheral blood stem cells in stage 4 neuroblastoma children. Proceedings of the American Association for Cancer Research Annual Meeting 41: 520

Garcia, C.D.; Barros, V.R.; Schneider, L.; Alves, M.D.; Silveira, C.G.; Garcia, V.D. 2002: IL-2 antibody induction and the outcome of pediatric renal transplants. Transplantation Proceedings 34(7): 2914-2915

Wagner, J.R.; Rosenberg, S.A.; Yang, J.C.; Linehan, W.M.; Walther, M.M. 1999: IL-2 based immunotherapy for metastatic renal cell carcinoma with kidney in place. Journal of Urology 161(4 Suppl): 166

Kasamon, Y.L.; Byrd, J.C.; Grever, M.R.; Diehl, L.F.; Lucas, M.S.; Garrett, E.S.; Flinn, I.W. 2003: IL-2 does not protect against fludarabine and cyclophosphamide induced immunosuppression. Blood 102(11): 637a

Almeida, A.J.; Baptista, M.J.; Roncon, S.; Evila, A.; Campos, A.; Pimentel, P.; Carvalhais, A.; Barbosa, I.L. 2001: IL-2 effect on NK cell phenotype of PBPC from healthy donors and patients. European Journal of Cancer 37(Suppl 6): S100

Lord, E.M.; Lee, J.; Moran, J.P.; Koch, C.J.; Frelinger, J.G.; Fenton, B.M.; Keng, P.G. 1999: IL-2 expression in a mouse mammary tumor increases vascularization, T cell infiltration and radiation sensitivity. Proceedings of the American Association for Cancer Research Annual Meeting 40: 422

Saparov, A.; Wagner, F.H.; Oliver, J.R.; Maeda, H.; Hockett, R.D.; Weaver, C.T. 1999: IL-2 gene expression by a subpopulation of antigen-activated primary T-cells is linked to effector cell differentiation. Immunology Letters 69(1): 109-110

Dix, R.D.; Laflam, P.; Enriquez Algeciras, M.; Hernandez, E.; Cousins, S.W. 1999: IL-2 immunotherapy upregulates perforin mRNA within MCMV-infected eyes of mice with maids. IOVS Investigative Ophthalmology and Visual Science 40(4): S584

Atzpodien, J.; Kirchner, H.; Miller, E.C.; Illiger, H.J.; Sybrecht, G.W.; Oesterwitz, H.; Funke, P.J.; Gramatzki, M.; Wandert, T.; Patzelt, T. 2000: IL-2 in combination with IFN-alpha and 5-FU in metastatic renal cell carcinoma 5-Year long term results of a controlled and randomised multicentric clinical trial. Onkologie 23(Sonderheft 7): 180

Barreiros, A.P.; Schlaak, J.; Schramm, C.; Bayer, E.; Gerken, G.; Galle, P.; Loehr, H. 2002: IL-2 induced immunocompetence in HIV/HBV or HIV/HCV coinfected patients under antiretroviral therapy. Gastroenterology 123(1 Suppl): 73

Barreiros, A.; Schlaak, J.; Schramm, C.; Bayer, E.; Galle, P.; Jaeger, H.; Loehr, H. 2001: IL-2 induced immunocompetence in HIV/HCV or HIV/HBV coinfected patients under antiretroviral therapy. Journal of Hepatology 34(Suppl 1): 215

Soto Cruz, I.; Valle Mendiola, A.; Rangel Corona, R.; Mendoza Rincon, J.F.; Weiss Steider, B. 2000: IL-2 induces JAK3, but not JAK1, tyrosine phosphorylation in cervical cancer cell lines CALO and INBL. Biochemical Society Transactions 28(5): A283

Capelli, E.; Civallero, M.; Nano, R.; Barni, S.; Cuccia, M. 2000: IL-2 involvement in dendritic cell differentiation. Human Immunology 61(Suppl 1): S147

Kish, D.D.; Gorbachev, A.V.; Fairchild, R.L.; Naramura, M. 2003: IL-2 mediates regulation but not clonal expansion of T cells in contact hypersensitivity. FASEB Journal 17(7): C80

Wei, S.; Liu, J.H.; Epling Burnette, P.K.; Djeu, J.Y. 2000: IL-2 modulates LYN and MAP protein kinase activity in human neutrophils. Proceedings of the American Association for Cancer Research Annual Meeting 41: 116

Spadaro, M.; Curcio, C.; Quaglino, E.; Cavallo, F.; Anton, I.; Pericle, F.; Forni, G. 2002: IL-2 once again But in a new tumor model with a new delivery system. Journal of Interferon and Cytokine Research 22(Suppl 1): S-169

Pilon, S.A.; Piechocki, M.P.; Nishisaka, N.; Wei, W.Z.n 2000: IL-2 or GM-CSF substitute for CD4 T cell help in cytErbB-2 DNA vaccination to induce anti-tumor immunity. Proceedings of the American Association for Cancer Research Annual Meeting 41: 796

Ariel, A.; Hershkoviz, R.; Cahalon, L.; Hardan, I.; Chowers, Y.; Lider, O. 1999: IL-2 peptides generated by elastase inhibit pro-inflammatory activities of PBL and colonic epithelial. Journal of Autoimmunity (Suppl ): 121

Almholt, D.L.C.; Jorgensen, T.N.; Thastrup, O.; Michelsen, B.K. 2000: IL-2 promoter activation in T cell hybridomas measured by GFP fluorescence. Scandinavian Journal of Immunology 52(3): 326

Nüssler, N.C.; O'Brien, J.; Stange, B.; Platz, K.P.; Neuhaus, P.; Müller, A.R. 2000: IL-2 promotes the subset restoration of intraepithelial lymphocytes after ischemia/reperfusion injury. Transplantation Proceedings 32(6): 1305-1306

Zhang, Y.; Xie, J.; Qian, L.; Schechter, J.E.; Mircheff, A.K. 2001: IL-2 receptor alpha subunit in lacrimal acinar cells. IOVS Investigative Ophthalmology and Visual Science 42(4): S920

Langrehr, J.M.; Lohmann, R.; Guckelberger, O.; Müller, A.R.; Raakow, R.; Nüssler, N.C.; Klupp, J.; Pfitzmann, R.; Jonas, S.; Settmacher, U.; Steinmüller, T.; Neuhaus, P. 2001: IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. Transplantation Proceedings 33(1-2): 1433-1434

Innocenti, F.; Humeres, R.; Zamboni, M.; Sanhueza, E.; Zapata, R.; Hepp, J.; Rius, M. 2003: IL-2 receptor blockers in liver transplantation: initial experience with daclizumab in Chile. Transplantation Proceedings 35(7): 2520-2521

Donnelly, R.P.; Feldman, G.M.; Dickensheets, H.L. 1999: IL-2 receptor gamma chain -deficient macrophages exhibit diminished responses to IL-4 but not IL-13. FASEB Journal 13(5 Part 2): A1152

Baan, C.C.; De Groot Kruseman, H.A.; Balk, A.H.M.M.; Klepper, M.; Vd Engel, S.; De Weger, R.; Niesters, H.G.M.; Weimar, W. 2002: IL-2 regulates the apoptotic death of graft infiltrating cells in human cardiac allografts by downregulating FLIP. Journal of Interferon and Cytokine Research 22(Suppl 1): S-171

Oliveira, J.G.G.; Xavier, P.; Sampaio, S.; Mendes, A.; Pestana, M. 2001: IL-2 synthesis does not correlate with IL-2SRalpha in kidney transplantation. Nephrology Dialysis Transplantation 16(6): A199

Oliveira, J.G.G.; Xavier, P.; Sampaio, S.; Mendes, A.; Pestana, M. 2001: IL-2 synthesis does not correlate with soluble IL-2 receptor alpha in kidney transplantation. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 863A

Meier, P.; Blanc, E. 2003: IL-2 system dysregulation alters activated CD4+ T cell proliferation in ESRF patients. Journal of the American Society of Nephrology 14(Abstracts Issue): 228A

Lewis, D.E.; Gross, K.; Ngtang, D.; Garcia, S.; Nannini, E.; Arduino, R. 2000: IL-2 therapy has differential effects on CD4+ and CD8+ T cells in HIV. Cytometry Suppl (10): 158

Stewart, R.J.G.; Den Otter, W.; Hill, F.W.G.; Kock, N.C. 1999: IL-2 therapy trials of ocular squamous cell carcinoma and vulval papilloma complex in cattle in Zimbabwe. Anticancer Research 19(3A): 2011

Nguyen, T.; Russell, J.H. 2001: IL-2 treatment enhances Fas signaling by relieving an early blockade of the Fas signaling pathway. FASEB Journal 15(5): A1211

Kuramshin, D.H.; Tolokonskaya, N.P.; Silkov, A.N.; Sennikov, S.V.; Kozlov, V.A. 1999: IL-2, IFN-gamma and IL-4 serum profiles in hepatitis C and mixed C+B infection. Cytokine 11(11): 950

Montanheiro, P.; Penalva, D.O.iveira, A.; Duarte, A.; Casseb, J. 2003: IL-2, IFN-gamma, IL-4, IL-10 production in PBMC obtained from HTLV-I, HIV-1, and coinfected patients in Sao Paulo, Brazil. AIDS Research and Human Retroviruses 19(Suppl): S-40

Levine, A.D.; Wong, V.L. 1999: IL-2-conditioning alters signaling via the CD2 and CD3 receptors in intestinal lamina propria T cells. Gastroenterology 116(4 Part 2): A562

Ueda, M.; Psarras, K.; Kitajima, M.; Seno, M.; Komatsu, S. 1999: IL-2-receptor dependent cytotoxicity of recombinant human RNasel-IL-2 fused protein for human cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 19

Zhang, J.; Ullrich, S.; Kao, V.; Wilkinson, K.; Ebner, R. 2000: IL-20 A novel proinflammatory cytokine that induces neutrophil migration in vivo. FASEB Journal 14(6): A1111

Wang, Y.C.; Li, H.H.; Chen, P.C.; Hsu, J.H.; Yang, J.J.; Chang, M.S. 2003: IL-20 Promoter analysis and characterization of biological function. European Cytokine Network 14(Suppl 3): 64

Liu, L.; Zeng, W.; Tetreault, J.; Noblitt, T.; Hangoc, G.; Cooper, S.; Ding, C.; Heuer, J.; Brune, K.; Fox, N.; Miller, J.; Witcher, D.; Broxmeyer, H. 2002: IL-20 Specifically Stimulates the Proliferation of Human and Murine Multipotential Hematopoietic Progenitors. Blood 100(11): Abstract No. 710

Xu, W.; Chandrasekher, Y.; Haugen, H.; Hughes, S.; Dillon, S.; Sivakumar, P.; Brender, T.; Waggie, K.; Yao, L.; Schlutsmeyer, S.; Anderson, M.; Kindsvogel, W.; Chen, Z. 2003: IL-20 and IL-22 in psoriasis. European Cytokine Network 14(Suppl 3): 65

Jin, H.; Carrio, R.; Malek, T.R. 2003: IL-21 induces apoptosis of LPS-activated B cells. FASEB Journal 17(7): C65

Law, J.Y.; Ozaki, K.; Qin, H.; Tian, L.; Stewart, D.M.; Leonard, W.J.; Nelson, D.L. 2002: IL-21 induces the release of sIL-2Ralpha from human peripheral blood mononuclear cells. Journal of Investigative Medicine 50(1): 73A

Lejeune, D.; Dumoutier, L.; Renauld, J.C.ristophe 2002: IL-22 activates the JAK/STAT, ERK, JNK and p38 MAP kinase pathways in a rat hepatoma cell line Shared and distinct pathways from IL-10. Journal of Interferon and Cytokine Research 22(Suppl 1): S-93-S-94

Fouser, L.A.; Lambert, A.J.; Clark, E.; Deng, B.; Tan, X.Y.; Spaulding, V.; Wang, I Ming; Kobayashi, M.; Whitters, M.; Thibodeaux, D.; Leonard, J.; Ling, V.; Wu, P.; Annis, B.; Lu, Z. 2001: IL-22 is a tightly regulated IL-10-like molecule that induces an acute-phase response and renal tubular basophilia. Journal of Leukocyte Biology Suppl: 26

Vaisberg, Elena; Travis, Marilyn; Rosales, Rency; De Waal Malefyt, Rene 2002: IL-23 acts on human NK cells and induces IFN-gamma production. FASEB Journal 16(4): A293-A294

Malefyt, R.D.W.; Blom, B.; Liu, Y.J.; Vaisberg, E.; Kastelein, R. 2002: IL-23 induces IL-12-independent differentiation of naive human T cells into Th1 cells. FASEB Journal 16(4): A684

Khader, Shabaana A.; Pearl, John; Gilmartin, Leigh; Jelly Gibbs, Dawn M.; Ghilardi, Nico; De Sauvage, Frederic J.; Cooper, Andrea M. 2004: IL-23 is important in IL-17 induction in Tuberculosis. FASEB Journal 18(4-5): Abstract 93

Kopp, T.; Lenz, P.; Bello Fernandez, C.; Kastelein, R.A.; Kupper, T.S.; Stingl, G. 2003: IL-23 production by cosecretion of endogenous p19 and transgenic p40 in K14/p40 transgenic mice Evidence for enhanced cutaneous immunity. Journal of Investigative Dermatology 121(5): 1238

Stallmach, A.; Ludwig, B.; Meuer, S.C.; Giese, T. 2002: IL-23- but not IL-18-transcripts were increased in patients with inflammatory bowel disease. Gastroenterology 122(4 Suppl 1): A-264-A-265

Pflanz, S.; Timans, J.C.; Cheung, J.; Rosales, R.; Kanzler, H.; Gilbert, J.; Hibbert, L.; Churakova, T.; Travis, M.; Vaisberg, E.; Blumenschein, W.M.; Mattson, J. 2003: IL-27, a heterodimeric cytokine composed of EB13 and P28 protein, induces proliferation of naive CD4+ T cells. European Cytokine Network 14(Suppl 3): 131

Webb, J.W.; Fullard, R.J. 1999: IL-2R as a marker for severity of squamous metaplasia in KCS. IOVS Investigative Ophthalmology and Visual Science 40(4): S559

Taniguchi, T.; Shibuya, H.; Barsoumian, E.L.on 2001: IL-2R-associated polypeptide and DNA molecules coding therefor. Official Gazette of the United States Patent and Trademark Office Patents 1251(1)

Decicco, K.L.; Zolfaghari, R.; Ross, A.C. 1999: IL-2Rbeta, IRF-1, and STAT-1 mRNA are reduced in vitamin A deficiency but recovered by treatment with retinoic acid and poly-IC-L,C in vivo. FASEB Journal 13(5 Part 2): A899

Porter, B.O.; Malek, T.R. 1999: IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial T cell defects of gammac-/-mice. FASEB Journal 13(5 Part 2): A1145

Nielsen, H.V.; Johnsen, A.H.; Schiotz, P.O. 2001: IL-3 and anti-IgE stimulate new synthesis of actin in purified human basophils. Journal of Allergy and Clinical Immunology 107(2): S288

Mora, E.M.; Mojica, P.L. 2000: IL-3 enhances the growth of bone-metastatic breast carcinoma cells by increasing the expression of Bcl-xl. Proceedings of the American Association for Cancer Research Annual Meeting 41: 406-407

Gordon, M.; Lewis, J.; Marley, S. 2003: IL-3 in combination with erythropoietin enhances erythroid cell proliferation via Jak/Stat and PI3 kinase signalling. Experimental Hematology (New York) 31(7 Suppl 1): 78-79

Groeger, M.; Loewe, R.; Holnthoner, W.; Embacher, R.; Pillinger, M.; Herron, S.; Wolff, K.; Petzelbauer, P. 2004: IL-3 induces expression of a lymphatic phenotype. Archives of Dermatological Research 295(8-9): 327

Groger, M.; Loewe, R.; Holnthoner, W.; Embacher, R.; Pillinger, M.; Herron, G.S.; Wolff, K.; Petzelbauer, P. 2004: IL-3 induces expression of lymphatic phenotypic markers. Journal of Investigative Dermatology 123(2)

Ehrlich, L.A.; Choi, S.J.; Chung, H.Y.; Roodman, G.D. 2003: IL-3 inhibits osteoblast differentiation in Multiple Myeloma. Blood 102(11): 442a

Malolepszy, J.; Zak Nejmark, T.; Jutel, M.; Nowak, I.A.; Nadobna, G. 2001: IL-3, TNFalpha and TGFbeta influence histamine binding by human mast cells. Allergy 56(Suppl 68): 130-131

Gross, J.A.; Sprecher, C.; Hammond, A.; Dillon, S.; Dasovich, M.; Kuijper, J.; Kramer, J.; Grant, F.; Presnell, S.; Gao, Z.; Whitmore, T.; Kuestner, R.; Maurer, M. 2003: IL-31, a novel cytokine made by activated T cells, signals through a novel hetero-dimeric receptor complex expressed in skin. European Cytokine Network 14(Suppl 3): 109

Jones,L.A.; Roberts,F.; Nickdel,M.B.; Brombacher,F.; McKenzie,A.N.J.; Henriquez,F.L.; Alexander,J.; Roberts,C.W. 2010: IL-33 receptor signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. European Journal Of Immunology: 2, 426-436

Hazlett, L.D.; McClellan, S.A.; Barrett, R.P.; Huang, X.; Zhang, Y.; Wu, M.; van Rooijen, N.; Szliter, E. 2010: IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Investigative Ophthalmology and Visual Science 51(3): 1524-1532

Woolard, M.D.; Hardy, R.D.; Simecka, J.W. 2004: IL-4 Dampens Methacoline Induced Airway Hyperreactivity During Pulmonary Mycoplasma Infection. FASEB Journal 18(4-5): Abstract 771

Moreno, J.; Celluzzi, C.; Kazmareck, M.; Keegan, A.; Tondravi, M. 2002: IL-4 Regulation of Osteoclast Differentiation and Activity. Blood 100(11): Abstract No. 936

Messingham, K.A.N.; Heinrich, S.A.; Kovacs, E.J. 2001: IL-4 administration restores immunity in male mice following ethanol exposure and burn injury. Journal of Leukocyte Biology Suppl: 78

Nikolova, D.; Marinova, E.; Aleksieva, B.; Bichkidjieva, E. 2000: IL-4 aggravates experimental autoimmune tubulointerstitial nephritis in BALB/C mice. Immunology Letters 73(2-3): 200-201

Rudge, E.R.; Cutler, A.J.; Pritchard, N.R.; Smith, K.G.C. 2000: IL-4 and CD40 reduce B cell negative regulators A new mechanism of T cell help?. Immunology 101(Suppl 1): 13

Marriott, I.; Bost, K.L. 2000: IL-4 and IFN-gamma up-regulate substance P receptor expression in murine peritoneal macrophages. Journal of Immunology 165(1): 182-191

Yeatman, C.F.; Mirmonsef, P.; Ryan, J.J. 1999: IL-4 and IL-10 co-stimulation of murine bone marrow-derived mast cells induces apoptosis via a Stat6-dependent mechanism. FASEB Journal 13(4 Part 1): A336

Van Den Berg, J.G.; Aten, J.; Annink, C.; Ravesloot, J.H.; Weening, J.J. 2000: IL-4 and IL-13 activate basolateral vacuolar-type H+-ATPase in rat glomerular visceral epithelial cells. Immunobiology 203(1-2): 149

Madden, K.B.; Yeung, K.A.; Zhao, A.; Urban, J.F.Jr.; Gause, W.; Katona, I.; Finkelman, F.; Shea Donohue, T. 2002: IL-4 and IL-13 downregulate intestinal epithelial cell responses to trypsin. Gastroenterology 122(4 Suppl 1): A 529

Levay Young, B.K.; Wahner, A.E.; Benson, B.A.; Koch, A.E.; Grehan, J.F.; Dalmasso, A.P. 2003: IL-4 and IL-13 gene transfer into porcine endothelial cells effectively induces cytokine production and protection from human complement and apoptosis. Xenotransplantation 10(5): 507

Grehan, J.F.; Fogelson, J.L.; Benson, B.A.; Levay Young, B.K.; Dalmasso, A.P. 2003: IL-4 and IL-13 induce cytoprotection in porcine endothelial cells against complement and apoptosis through activation of a PI-3 kinase/Akt pathway. Xenotransplantation 10(5): 508

Woods, M.; Walcot, N.R.; Wood, E.G.; Mitchell, J.A.; Warner, T.D. 2000: IL-4 and IL-13 modulate cytokine-induced endothelin-1 production in human vascular smooth muscle cells. British Journal of Pharmacology 129(Proceedings Suppl): 203P

Durual, S.; Blanchard, C.; Boncoeur, E.; Estienne, M.; Cuber, J.C.aude 2002: IL-4 and IL-13 stimulate the expression of trefoil factor family-3 from intestinal goblet cell lines Requirement of de novo protein synthesis. Gastroenterology 122(4 Suppl 1): A-273

Racke, K.; Lindemann, D.; Fuhrmann, M. 2003: IL-4 and IL-13 up-regulate arginase in rat primary airway fibroblasts. Amino Acids 25(2): 164

Wei, L.; Jacobs, A.; Morris, S.; Ignarro, L. 2000: IL-4 and IL-13 upregulate arginase I expression by cyclic AMP and possible JAK/STAT6 pathways in vascular smooth muscle cells. Nitric Oxide 4(3): 233

Bijlsma, F.; De Snoo, M.; Van Kuik, J.; De Jonge, N.; Tilanus, M.; Gmelig Meyling, F.; De Weger, R. 2001: IL-4 and IL-4 receptor alpha gene polymorphism in heart transplantation. Human Immunology 62(Suppl 1): S170

Vasilenko, R.N.; Puchkova, G.Y.; Kosarev, I.V.; Khodyakova, A.V.; Vasiliev, A.M.; Chikileval, I.O.; Sharova, N.I.; Yarilin, A.A.; Ptitsyn, L.P.; Abramov, V.M. 2001: IL-4 and IL-4delta2 as a system of immune response regulation. Journal of Interferon and Cytokine Research 24(Suppl 1): S 91

Sozanska, B.; Boznanski, A.; Hebrowska, A. 2001: IL-4 and INF-g expression in stimulated PBMC of children with respiratory syncytial virus diseases. Allergy 56(Suppl 68): 44

Hoontrakoon, R.; Kailey, J.M.; Bratton, D.L. 1999: IL-4 and TNFalpha synergize to enhance eosinophil survival. Journal of Allergy and Clinical Immunology 103(1 Part 2): S239

Mcgowan, J.P.; Shah, S.S.; Rodicio, I.; Blum, S.; Muck, P.; Small, C.B. 2000: IL-4 and interferon-gamma production and serum IgE levels in subjects infected with HIV. Clinical Infectious Diseases 31(1): 272

Wittmann, M.; Meyer, S.; Stephan, E.; Kapp, A.; Schmid Ott, G.; Werfel, T. 2001: IL-4 and noradrenaline are involved in an increased heat-shock response upon mental stress which is prolonged in atopic subjects. Allergy 56(Suppl 68): 8

Menetrier Caux, C.; Montmain, G.; Magaud, J.P.; Caux, C.; Blay, B.Y. 1999: IL-4 antagonizes the inhibition of dendritic cell differentiation from CD34+ progenitor cells induced by tumor cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 655-656

Lian, M.; Yang, X.; Li, Y.; Ye, R.; Yu, X. 2002: IL-4 augment RANTES production by murine renal tubular epithelial cells requires calcineurin activation. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 744A

Berger, P.; Molimard, M.; Tunon Delara, J.M.nuel 2001: IL-4 but not IL-13 decreases relaxation response of human isolated bronchi. Journal of Allergy and Clinical Immunology 107(2): S40

Soruri, A.; Fayyazi, A.; Koehl, J.; Zwirner, J. 2000: IL-4 but not LPS inhibits the targeted migration of murine dendritic cells in vivo. Immunobiology 203(1-2): 390